AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
1 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
Z2
N1
ST
GE
N A
NT
IHIS
T/D
EC
NG
ES
T C
OM
B
BR
OM
PH
EN
IRA
MIN
E &
PH
EN
YLE
PH
RIN
E
RE
SP
AH
IST
-II
OR
AL
NO
BR
OM
PH
EN
IRA
MIN
E &
PS
EU
DO
EP
HE
DR
INE
BR
OV
EX
SR
OR
AL
NO
CH
LOR
PH
EN
IRA
MIN
E &
PS
EU
DO
EP
HE
DR
INE
WA
L-F
INA
TE
-DO
RA
LN
OC
HLO
RP
HE
NIR
AM
INE
TA
N-P
HE
NY
LEP
HR
INE
TA
ND
ALL
ER
GY
-JR
OR
AL
NO
DIP
HE
NH
YD
RA
MIN
E T
AN
-PH
EN
YLE
PH
RIN
E
TA
N
DIP
HE
NM
AX
DO
RA
LN
O
PR
OM
ET
HA
ZIN
E &
PH
EN
YLE
PH
RIN
E
PR
OM
ET
HA
ZIN
E V
CO
RA
LN
O
PY
RIL
AM
INE
-PH
EN
YLE
PH
RIN
EP
OLY
HIS
T F
OR
TE
OR
AL
NO
Z2
O2
ND
GE
N A
NT
IHIS
T-D
EC
ON
G C
MB
AC
RIV
AS
TIN
E &
PS
EU
DO
EP
HE
DR
INE
SE
MP
RE
X-D
OR
AL
YE
S
CE
TIR
IZIN
E-P
SE
UD
OE
PH
ED
RIN
EC
ET
IRIZ
INE
-PS
EU
DO
EP
HE
DR
INE
OR
AL
YE
S
CE
TIR
IZIN
E-P
SE
UD
OE
PH
ED
RIN
E
ZY
RT
EC
-DO
RA
LY
ES
DE
SLO
RA
TA
DIN
E &
PS
EU
DO
EP
HE
DR
INE
CLA
RIN
EX
-D 1
2 H
OU
RO
RA
LY
ES
FE
XO
FE
NA
DIN
E-P
SE
ER
FE
XO
FE
NA
DIN
E-P
SE
ER
OR
AL
YE
S
FE
XO
FE
NA
DIN
E-P
SE
UD
OE
PH
ED
RIN
EA
LLE
GR
A-D
12
HO
UR
OR
AL
YE
S
LOR
AT
AD
INE
A
LAV
ER
TO
RA
LY
ES
LOR
AT
AD
INE
& P
SE
UD
OE
PH
ED
RIN
E
LOR
AT
A-D
OR
AL
YE
S
W4
G2
ND
GE
N A
NT
IPR
OT
OZ
OA
L-A
NT
IBA
CT
TIN
IDA
ZO
LE
TIN
DA
MA
XO
RA
LN
O
Z4
E5
-LIP
OX
YG
EN
AS
E I
NH
IBIT
OR
S
ZIL
EU
TO
NZ
YF
LOO
RA
LY
ES
W2
AA
BS
OR
BA
BLE
SU
LFO
NA
MID
ES
SU
LFA
DIA
ZIN
ES
ULF
AD
IAZ
INE
OR
AL
NO
SU
LFA
ME
TH
OX
AZ
OLE
-TR
IME
TH
OP
RIM
BA
CT
RIM
DS
OR
AL
NO
SU
LFA
SA
LAZ
INE
SU
LFA
SA
LAZ
INE
OR
AL
NO
A4
JA
CE
IN
HIB
/TH
IAZ
IDE
CO
MB
O
BE
NA
ZE
PR
IL-
HC
TZ
BE
NA
ZE
PR
IL H
CL-
HC
TZ
OR
AL
YE
S
CA
PT
OP
RIL
- H
CT
ZC
AP
TO
PR
IL-H
CT
ZO
RA
LY
ES
EN
ALA
PR
IL M
ALE
AT
E -
HC
TZ
EN
ALA
PR
IL M
ALE
AT
E-H
CT
ZO
RA
LY
ES
FO
SIN
OP
RIL
SO
DIU
M -
HC
TZ
FO
SIN
OP
RIL
- H
CT
ZO
RA
LY
ES
LIS
INO
PR
IL -
HC
TZ
ZE
ST
OR
ET
ICO
RA
LY
ES
MO
EX
IPR
IL-H
CT
ZU
NIR
ET
ICO
RA
LY
ES
QU
INA
PR
IL-H
CT
ZQ
UIN
AR
ET
ICO
RA
LY
ES
A4
KA
CE
IN/C
AL
CH
NL
BLO
CK
CO
MB
O
AM
LOD
IPIN
E B
ES
YLA
TE
-BE
NA
ZE
PR
ILLO
TR
EL
OR
AL
YE
S
TR
AN
DO
LAP
RIL
-VE
RA
PA
MIL
HC
L T
AR
KA
OR
AL
YE
S
ACTION: Final DATE: 08/19/2011 4:16 PMENACTEDAppendix
4123-6-21.3
APPENDIX p(83037) pa(144381) d(341189) ra(284272) print date: 08/19/2011 9:33 PM
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
2 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
L1B
AC
NE
AG
EN
TS
SY
ST
EM
IC
ISO
TR
ET
INO
IN
CLA
RA
VIS
OR
AL
NO
L5H
AC
NE
AG
EN
TS
TO
PIC
AL
SU
LFA
CE
TA
MID
E S
OD
IUM
KLA
RO
NT
OP
ICA
LN
O
H8
MA
DH
D-T
X-A
LPH
A-2
A-R
EC
EP
-AG
ON
IST
GU
AN
FA
CIN
E H
CL
INT
UN
IVO
RA
LN
O
J5B
AD
RE
NE
RG
IC A
GE
NT
S,
AR
OM
AT
IC,
AM
PH
ET
AM
INE
-DE
XT
RO
AM
PH
ET
AM
INE
A
DD
ER
ALL
OR
AL
YE
S
DE
XT
RO
AM
PH
ET
AM
INE
SU
LFA
TE
D
EX
ED
RIN
EO
RA
LY
ES
LIS
DE
XA
MF
ET
AM
INE
DIM
ES
YLA
TE
VY
VA
NS
EO
RA
LY
ES
J7A
AD
RE
NE
RG
IC I
NH
IBIT
OR
S
CA
RV
ED
ILO
LC
OR
EG
OR
AL
YE
S
LAB
ET
ALO
L H
CL
NO
RM
OD
YN
EO
RA
LY
ES
J5H
AD
RE
NE
RG
IC V
AS
OP
RE
SS
OR
AG
TS
MID
OD
RIN
E H
CL
PR
OA
MA
TIN
EO
RA
LY
ES
P1
EA
DR
EN
OC
OR
TIC
OT
RO
PH
IC H
OR
MO
NE
CO
RT
ICO
TR
OP
INA
CT
HA
R H
.P.
INJE
CT
ION
YE
S
H0
EA
GE
NT
S T
O T
RE
AT
MS
GLA
TIR
AM
ER
AC
ET
AT
EC
OP
AX
ON
ES
UB
-QY
ES
INT
ER
FE
RO
N B
ET
A-1
A
AV
ON
EX
INT
RA
MU
SC
YE
S
INT
ER
FE
RO
N B
ET
A-1
A
RE
BIF
SU
B-Q
YE
S
V1
AA
LKY
LAT
ING
AG
EN
TS
CY
CLO
PH
OS
PH
AM
IDE
CY
CLO
PH
OS
PH
AM
IDE
OR
AL
YE
S
J7B
ALP
HA
AD
RE
NE
RG
IC B
LOC
KIN
G A
G
DIB
EN
ZY
LIN
ED
IBE
NZ
YLI
NE
OR
AL
YE
S
DO
XA
ZO
SIN
ME
SY
LAT
EC
AR
DU
RA
OR
AL
YE
S
PR
AZ
OS
IN H
CL
MIN
IPR
ES
SO
RA
LY
ES
TE
RA
ZO
SIN
HC
LT
ER
AZ
OS
IN H
CL
OR
AL
YE
S
H7
BA
LPH
A-2
AN
TA
GO
NIS
T A
NT
IDE
PR
ES
S
MIR
TA
ZA
PIN
ER
EM
ER
ON
OR
AL
NO
H1
AA
LZH
EIM
ER
S T
X-N
MD
A R
EC
EP
AN
TA
G
ME
MA
NT
INE
HC
L N
AM
EN
DA
OR
AL
YE
S
W1
FA
MIN
OG
LYC
OS
IDE
S
AM
IKA
CIN
SU
LFA
TE
A
MIK
AC
IN S
ULF
AT
E I
NJ
25
0 M
G/M
L
INJ
NO
GE
NT
AM
ICIN
SU
LFA
TE
GE
NT
AM
ICIN
SU
LFA
TE
IN
J 4
0 M
G/M
L
IN
JN
O
NE
OM
YC
IN S
ULF
AT
EN
EO
MY
CIN
SU
LFA
TE
OR
AL
NO
TO
BR
AM
YC
IN S
ULF
AT
ET
OB
RA
MY
CIN
NE
BU
SO
LNN
O
D9
AA
MM
ON
IA I
NH
IBIT
OR
S
AC
ET
OH
YD
RO
XA
MIC
AC
IDLI
TH
OS
TA
TO
RA
LN
O
LAC
TU
LOS
E (
EN
CE
PH
ALO
PA
TH
Y)
EN
ULO
SE
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
3 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
H6
IA
MY
OT
RO
PH
IC L
AT
ER
AL
SC
LER
OS
RIL
UZ
OLE
R
ILU
TE
KO
RA
LN
O
H3
EA
NA
LGE
SIC
/AN
TIP
YR
ET
ICS
, N
ON
AC
ET
AM
INO
PH
EN
TY
LEN
OL
OR
AL
NO
AC
ET
AM
INO
PH
EN
-CA
FF
EIN
E
EX
CE
DR
IN T
EN
SIO
N H
EA
DA
CH
EO
RA
LN
O
F1
AA
ND
RO
GE
NIC
AG
EN
TS
ME
TH
YLT
ES
TO
ST
ER
ON
EA
ND
RO
IDO
RA
LY
ES
OX
AN
DR
OLO
NE
O
XA
ND
RO
LON
EO
RA
LY
ES
TE
ST
OS
TE
RO
NE
BU
CC
AL
ST
RIA
NT
BU
CC
AL
YE
S
TE
ST
OS
TE
RO
NE
TD
A
ND
RO
DE
RM
TR
AN
SD
ER
MY
ES
A4
IA
NG
RE
C A
NT
G I
I T
HIA
Z C
OM
BO
CA
ND
ES
AR
TA
N C
ILE
XE
TIL
-HC
TZ
A
TA
CA
ND
HC
TO
RA
LY
ES
EP
RO
SA
RT
AN
ME
SY
LAT
E-H
CT
ZT
EV
ET
EN
HC
TO
RA
LY
ES
IRB
ES
AR
TA
N-
HC
TZ
AV
ALI
DE
OR
AL
YE
S
LOS
AR
TA
N P
OT
AS
SIU
M -
HC
TZ
HY
ZA
AR
OR
AL
YE
S
OLM
ES
AR
TA
N M
ED
OX
OM
IL-H
CT
ZB
EN
ICA
R H
CT
OR
AL
YE
S
TE
LMIS
AR
TA
N-H
CT
ZM
ICA
RD
IS H
CT
OR
AL
YE
S
VA
LSA
RT
AN
-HC
TZ
DIO
VA
N H
CT
OR
AL
YE
S
A4
VA
NG
IOT
EN
-RE
C A
NT
/CA
-CH
BLK
R/T
HZ
AM
LOD
IPIN
E-V
ALS
AR
TA
N-H
CT
ZE
XF
OR
GE
HC
TO
RA
LN
O
A4
HA
NG
-RE
C A
NT
G C
A C
HA
N B
LCK
RA
MLO
DIP
INE
BE
SY
LAT
E-O
LME
SA
RT
AN
ME
DO
XO
MIL
AZ
OR
OR
AL
YE
S
AM
LOD
IPIN
E B
ES
YLA
TE
-VA
LSA
RT
AN
E
XF
OR
GE
OR
AL
YE
S
J8A
AN
OR
EX
IC A
GE
NT
S
BE
NZ
PH
ET
AM
INE
HC
LB
EN
ZP
HE
TA
MIN
E H
CL
OR
AL
NO
D4
BA
NT
AC
IDS
All
co
mb
ina
tio
ns
an
d o
ral
do
sag
e f
orm
s a
re c
ov
ere
d
ALU
M &
MA
G H
YD
RO
XID
E-S
IME
TH
ICO
NE
R
ULO
XO
RA
LN
O
ALU
MIN
UM
& M
AG
NE
SIU
M H
YD
RO
XID
ES
A
LAM
AG
OR
AL
NO
ALU
MIN
UM
HY
DR
OX
IDE
A
LTE
RN
AG
EL
OR
AL
NO
ALU
MIN
UM
HY
DR
OX
IDE
-MA
GN
ES
IUM
TR
ISIL
ICA
TE
G
AV
ISC
ON
OR
AL
NO
CA
LCIU
M C
AR
BO
NA
TE
T
UM
SO
RA
LN
O
CA
LCIU
M C
AR
BO
NA
TE
-MA
G H
YD
RO
XID
EM
YLA
NT
A U
LTR
AO
RA
LN
O
CA
LCIU
M C
AR
BO
NA
TE
-MA
G H
YD
RO
XID
E
RO
LAID
SO
RA
LN
O
Ina
ctiv
eP
HIL
LIP
S'
MIL
K O
F M
AG
NE
SIA
OR
AL
NO
SO
DIU
M B
ICA
RB
ON
AT
ES
OD
IUM
BIC
AR
BO
NA
TE
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
4 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
C0
DA
NT
IALC
OH
OLI
C P
RE
PA
RA
TIO
NS
AC
AM
PR
OS
AT
E C
ALC
IUM
CA
MP
RA
LO
RA
LY
ES
DIS
ULF
IRA
M
AN
TA
BU
SE
OR
AL
YE
S
A2
CA
NT
IAN
GIN
AL
AN
TI
ISC
HE
MIC
DR
UG
RA
NO
LAZ
INE
RA
NE
XA
OR
AL
YE
S
H2
FA
NT
I-A
NX
IET
Y D
RU
GS
ALP
RA
ZO
LAM
X
AN
AX
OR
AL
NO
BU
SP
IRO
NE
HC
LB
US
PA
RO
RA
LN
O
CH
LOR
DIA
ZE
PO
XID
E H
CL
LIB
RIU
MO
RA
LN
O
CLO
RA
ZE
PA
TE
DIP
OT
AS
SIU
MT
RA
NX
EN
EO
RA
LN
O
CLO
RA
ZE
PA
TE
DIP
OT
AS
SIU
M
TR
AN
XE
NE
T-T
AB
OR
AL
NO
DIA
ZE
PA
MV
ALI
UM
OR
AL
NO
LOR
AZ
EP
AM
A
TIV
AN
OR
AL
NO
ME
PR
OB
AM
AT
EM
ILT
OW
NO
RA
LN
O
OX
AZ
EP
AM
SE
RA
XO
RA
LN
O
A2
AA
NT
IAR
RH
YT
HM
ICS
A2
DA
NT
IAR
RH
YT
HM
ICS
AM
IOD
AR
ON
E H
CL
PA
CE
RO
NE
OR
AL
YE
S
DO
FE
TIL
IDE
TIK
OS
YN
OR
AL
YE
S
DR
ON
ED
AR
ON
EM
ULT
AQ
OR
AL
YE
S
FLE
CA
INID
E A
CE
TA
TE
TA
MB
OC
OR
OR
AL
YE
S
ME
XIL
ET
INE
HC
LM
EX
ILE
TIN
E H
CL
OR
AL
YE
S
PR
OP
AF
EN
ON
E H
CL
RY
TH
MO
L
OR
AL
YE
S
PR
OP
AF
EN
ON
E H
CL
RY
TH
MO
L S
RO
RA
LY
ES
QU
INID
INE
GLU
CO
NA
TE
QU
INID
INE
GLU
CO
NA
TE
OR
AL
YE
S
S2
NA
NT
IAR
TH
RIC
S F
OLA
TE
AN
TA
G A
GT
ME
TH
OT
RE
XA
TE
SO
DIU
MR
HE
UM
AT
RE
XO
RA
LY
ES
S2
KA
NT
IAR
TH
RIT
IC/C
HE
LAT
ING
AG
EN
TS
PE
NIC
ILLA
MIN
EC
UP
RIM
INE
OR
AL
YE
S
S2
HA
NT
IAR
TH
RIT
ICS
AG
EN
TS
MIS
C.
GLU
CO
SA
MIN
E S
ULF
AT
EG
LUC
OS
AM
INE
SU
LFA
TE
OR
AL
YE
S
GLU
CO
SA
MIN
E-C
HO
ND
RO
ITIN
AR
TH
X D
SO
RA
LY
ES
J2D
AN
TIC
HO
LIN
ER
GIC
S,
AN
TIS
PA
SM
O
DIC
YC
LOM
INE
HC
LB
EN
TY
LO
RA
LN
O
J2B
AN
TIC
HO
LIN
ER
GIC
S,
QU
AN
TE
RN
AR
CH
LOR
DIA
ZE
PO
XID
E-C
LID
INIU
MLI
BR
AX
OR
AL
NO
GLY
CO
PY
RR
OLA
TE
RO
BIN
UL
OR
AL
NO
PR
OP
AN
TH
ELI
NE
BR
OM
IDE
PR
O-B
AN
TH
INE
OR
AL
NO
H4
BA
NT
ICO
NV
ULS
AN
TS
CA
RB
AM
AZ
EP
INE
TE
GR
ET
OL
OR
AL
NO
CLO
NA
ZE
PA
MK
LON
OP
INO
RA
LN
O
DIA
ZE
PA
M
DIA
ST
AT
AC
UD
IAL
RE
CT
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
5 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
AN
TIC
ON
VU
LSA
NT
S (
CO
NT
)D
IVA
LPR
OE
X S
OD
IUM
DE
PA
KO
TE
OR
AL
NO
ET
HO
SU
XIM
IDE
ZA
RO
NT
INO
RA
LN
O
FE
LBA
MA
TE
FE
LBA
TO
LO
RA
LN
O
GA
BA
PE
NT
IN
NE
UR
ON
TIN
OR
AL
NO
LAM
OT
RIG
INE
LAM
ICT
AL
OR
AL
NO
ME
PH
OB
AR
BIT
AL
ME
BA
RA
LO
RA
LN
O
OX
CA
RB
AZ
EP
INE
TR
ILE
PT
AL
OR
AL
NO
PH
EN
YT
OIN
SO
DIU
M
DIL
AN
TIN
OR
AL
NO
PR
IMID
ON
EM
YS
OLI
NE
OR
AL
NO
TO
PIR
AM
AT
E
TO
PA
MA
XO
RA
LN
O
VA
LPR
OIC
AC
IDS
TA
VZ
OR
OR
AL
NO
H4
CA
NT
ICO
NV
ULS
AN
TS
(C
ON
T)
LAC
OS
AM
IDE
VIM
PA
TO
RA
LN
O
LEV
ET
IRA
CE
TA
MK
EP
PR
AO
RA
LN
O
PR
EG
AB
ALI
N
LYR
ICA
OR
AL
NO
TIA
GA
BIN
E H
CL
GA
BIT
RIL
OR
AL
NO
ZO
NIS
AM
IDE
ZO
NE
GR
AN
OR
AL
NO
D4
DA
NT
IDIA
RR
HE
AL
MIC
RO
AG
EN
TS
LAC
TO
BA
CIL
LUS
BA
CID
OR
AL
NO
LAC
TO
BA
CIL
LUS
LA
CT
INE
XO
RA
LN
O
LAC
TO
BA
CIL
LUS
RH
AM
NO
SU
S (
GG
)C
ULT
UR
ELL
EO
RA
LN
O
PR
OB
IOT
IC P
RO
DU
CT
ALI
GN
OR
AL
NO
PR
OB
IOT
IC P
RO
DU
CT
RIS
AQ
UA
DO
RA
LN
O
SA
CC
HA
RO
MY
CE
S B
OU
LAR
DII
F
LOR
AS
TO
RO
RA
LN
O
D6
DA
NT
IDIA
RR
HE
ALS
BIS
MU
TH
SU
BS
ALI
CY
LAT
E
PE
PT
O-B
ISM
OL
OR
AL
NO
DIF
EN
OX
IN W
/ A
TR
OP
INE
M
OT
OF
EN
OR
AL
NO
DIP
HE
NO
XY
LAT
E W
/ A
TR
OP
INE
LOM
OT
ILO
RA
LN
O
LOP
ER
AM
IDE
IMO
DIU
M A
-DO
RA
LN
O
PA
RE
GO
RIC
P
AR
EG
OR
ICO
RA
LN
O
P2
BA
NT
IDIU
RE
TIC
AN
D V
AS
OP
RE
SS
OR
DE
SM
OP
RE
SS
IN A
CE
TA
TE
D
DA
VP
INJE
CT
ION
YE
S
H6
JA
NT
I-E
ME
TIC
S
AP
RE
PIT
AN
TE
ME
ND
OR
AL
YE
S
DIM
EN
HY
DR
INA
TE
D
RA
MA
MIN
EO
RA
LY
ES
DO
LAS
ET
RO
N M
ES
YLA
TE
AN
ZE
ME
TO
RA
LY
ES
DR
ON
AB
INO
L M
AR
INO
LO
RA
LY
ES
GR
AN
ISE
TR
ON
HC
LK
YT
RIL
OR
AL
YE
S
ME
CLI
ZIN
E H
CL
AN
TIV
ER
TO
RA
LY
ES
ON
DA
NS
ET
RO
N H
CL
ZO
FR
AN
OR
AL
YE
S
PR
OC
HLO
RP
ER
AZ
INE
MA
LEA
TE
CO
MP
AZ
INE
OR
AL
YE
S
PR
OC
HLO
RP
ER
AZ
INE
MA
LEA
TE
CO
MP
AZ
INE
RE
CT
AL
YE
S
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
6 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
AN
TI-
EM
ET
ICS
(C
ON
T)
PR
OM
ET
HA
ZIN
E H
CL
PH
EN
ER
GA
NO
RA
LY
ES
PR
OM
ET
HA
ZIN
E H
CL
PH
EN
ER
GA
NR
EC
TA
LY
ES
SC
OP
OLA
MIN
E H
YD
RO
BR
OM
IDE
SC
OP
AC
EO
RA
LY
ES
SC
OP
OLA
MIN
E T
D
TR
AN
SD
ER
M-S
CO
PT
RA
NS
DE
RM
YE
S
TR
IME
TH
OB
EN
ZA
MID
E H
CL
TIG
AN
OR
AL
YE
S
M9
DA
NT
IFIB
RIN
OLY
TIC
AG
EN
TS
AM
INO
CA
PR
OIC
AC
IDA
MIN
OC
AP
RO
IC A
CID
OR
AL
NO
D4
NA
NT
IFLA
TU
LEN
TS
SIM
ET
HIC
ON
E
SIM
ET
HIC
ON
EO
RA
LN
O
W3
BA
NT
IFU
NG
AL
AG
EN
TS
W3
BA
NT
IFU
NG
AL
AG
EN
TS
W3
CA
NT
IFU
NG
AL
AG
EN
TS
CLO
TR
IMA
ZO
LEC
LOT
RIM
AZ
OLE
MU
CO
US
ME
MN
O
CLO
TR
IMA
ZO
LEM
YC
ELE
XM
UC
OU
S M
EM
NO
FLU
CO
NA
ZO
LEF
LUC
ON
AZ
OLE
OR
AL
NO
ITR
AC
ON
AZ
OLE
SP
OR
AN
OX
OR
AL
NO
KE
TO
CO
NA
ZO
LEK
ET
OC
ON
AZ
OLE
OR
AL
NO
TE
RB
INA
FIN
E H
CL
LAM
ISIL
OR
AL
NO
W3
DA
NT
IFU
NG
AL
AG
EN
TS
(C
ON
T 2
)
PO
SA
CO
NA
ZO
LEN
OX
AF
ILO
RA
LN
O
VO
RIC
ON
AZ
OLE
VF
EN
DO
RA
LN
O
W3
AA
NT
IFU
NG
AL
AN
TIB
IOT
ICS
GR
ISE
OF
ULV
IN
GR
IFU
LVIN
VO
RA
LN
O
ME
FLO
QU
INE
HC
L M
EF
LOQ
UIN
E H
CL
OR
AL
NO
NY
ST
AT
INN
YS
TA
TIN
OR
AL
NO
Z2
PA
NT
IHIS
TA
MIN
ES
- 1
ST
GE
NE
RA
TIO
BR
OM
PH
EN
IRA
MIN
E &
PS
EU
DO
EP
HE
DR
INE
LO
DR
AN
EO
RA
LN
O
BR
OM
PH
EN
IRA
MIN
E M
ALE
AT
ELO
HIS
T 1
2H
RO
RA
LN
O
CA
RB
INO
XA
MIN
E M
ALE
AT
EC
AR
BIN
OX
AM
INE
MA
LEA
TE
OR
AL
NO
CA
RB
INO
XA
MIN
E M
ALE
AT
EP
ALG
ICO
RA
LN
O
CLE
MA
ST
INE
FU
MA
RA
TE
CLE
MA
ST
INE
FU
MA
RA
TE
OR
AL
NO
CY
PR
OH
EP
TA
DIN
E H
CL
CY
PR
OH
EP
TA
DIN
E H
CL
OR
AL
NO
DIP
HE
NH
YD
RA
MIN
E H
CL
BE
NA
DR
YL
OR
AL
NO
DIP
HE
NH
YD
RA
MIN
E H
CL
DIP
HE
NH
YD
RA
MIN
E H
CL
INJE
CT
ION
NO
DIP
HE
NH
YD
RA
MIN
E T
AN
NA
TE
DIP
HE
NM
AX
OR
AL
NO
HY
DR
OX
YZ
INE
HC
LH
YD
RO
XY
ZIN
E H
CL
OR
AL
NO
PR
OM
ET
HA
ZIN
E H
CL
PH
EN
ER
GA
NO
RA
LN
O
Z2
QA
NT
IHIS
TA
MIN
ES
- 2
ND
GE
NE
RA
TIO
CE
TIR
IZIN
E H
CL
ZY
RT
EC
OR
AL
YE
S
DE
SLO
RA
TA
DIN
E
CLA
RIN
EX
OR
AL
YE
S
DIP
HE
NH
YD
RA
MIN
E H
CL
ALL
ER
GY
RE
LIE
FO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
7 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
AN
TIH
IST
AM
INE
S -
2N
D G
EN
ER
AT
IO (
CO
NT
)F
EX
OF
EN
AD
INE
HC
L A
LLE
GR
AO
RA
LY
ES
Ina
ctiv
eN
ON
-DR
OW
SY
ALL
ER
GY
OR
AL
YE
S
LEV
OC
ET
IRIZ
INE
DIH
YD
RO
CH
LOR
IDE
XY
ZA
LO
RA
LY
ES
LOR
AT
AD
INE
C
LEA
R-A
TA
DIN
EO
RA
LY
ES
B5
SA
NT
IHIS
T-A
NA
LGE
SIC
,NO
N,S
AL
DIP
HE
NH
YD
RA
MIN
E W
/ A
PA
P T
AB
EX
CE
DR
IN P
.M.
OR
AL
NO
PH
EN
YLT
OLO
XA
MIN
E W
/ A
PA
P
FLE
XT
RA
-65
0O
RA
LN
O
B3
XA
NT
IHIS
T-D
EC
ON
G-A
NT
ICH
OLI
N-C
MB
CH
LOR
PH
EN
-PS
E-A
TR
OP
INE
-HY
OS
-SC
OP
OL
TA
B S
RR
U-T
US
SO
RA
LN
O
PE
-ME
TH
SC
OP
TA
BA
LLE
RX
PE
OR
AL
NO
C4
FA
NT
IHY
PE
RG
LY,D
PP
4 I
NH
IB+
BIG
UA
N
SIT
AG
LIP
TIN
-ME
TF
OR
MIN
JA
NU
ME
TO
RA
LY
ES
C4
JA
NT
IHY
PE
RG
LYC
EM
IC D
PP
-4 I
NH
IB
SIT
AG
LIP
TIN
PH
OS
PH
AT
E
JAN
UV
IAO
RA
LY
ES
C4
IA
NT
I-H
YP
ER
GLY
CIC
,IN
CR
ET
IN-M
IMT
EX
EN
AT
IDE
B
YE
TT
AS
UB
-QY
ES
LIR
AG
LUT
IDE
LIR
AG
LUT
IDE
IN
J S
UB
-QY
ES
C4
HA
NT
I-H
YP
ER
GLY
CIC
-AM
YLI
N-A
NA
LOG
PR
AM
LIN
TID
E A
CE
TA
TE
SY
MLI
NS
UB
-QY
ES
W4
AA
NT
IMA
LAR
IAL
DR
UG
S
CH
LOR
OQ
UIN
E P
HO
SP
HA
TE
CH
LOR
OQ
UIN
E P
HO
SP
HA
TE
OR
AL
NO
HY
DR
OX
YC
HLO
RO
QU
INE
SU
LFA
TE
HY
DR
OX
YC
HLO
RO
QU
INE
SU
LFA
TE
OR
AL
NO
QU
ININ
E S
ULF
AT
E
QU
ALA
QU
INO
RA
LN
O
H2
MA
NT
I-M
AN
IA D
RU
GS
CA
RB
AM
AZ
EP
INE
T
EG
RE
TO
LO
RA
LN
O
LIT
HIU
M C
AR
BO
NA
TE
ES
KA
LIT
HO
RA
LN
O
LIT
HIU
M C
ITR
AT
EC
IBA
LIT
H-S
OR
AL
NO
V1
BA
NT
IME
TA
BO
LIT
ES
CA
PE
CIT
AB
INE
XE
LOD
AO
RA
LY
ES
ME
TH
OT
RE
XA
TE
ME
TH
OT
RE
XA
TE
OR
AL
YE
S
H3
FA
NT
IMIG
RA
INE
PR
EP
AR
AT
ION
S
ALM
OT
RIP
TA
N M
ALA
TE
AX
ER
TO
RA
LY
ES
12
un
its
pe
r 3
0 d
ay
s
AP
AP
-IS
OM
ET
HE
PT
EN
E-D
ICH
LOR
AL
EP
IDR
INO
RA
LY
ES
DIH
YD
RO
ER
GO
TA
MIN
E M
ES
YLA
TE
MIG
RA
NA
LN
AS
AL
YE
S
ELE
TR
IPT
AN
HY
DR
OB
RO
MID
ER
ELP
AX
OR
AL
YE
S6
un
its
pe
r 3
0 d
ay
s
ER
GO
TA
MIN
E T
AR
TR
AT
EE
RG
OM
AR
SU
BLI
NG
UA
LY
ES
ER
GO
TA
MIN
E-C
AF
FE
INE
ER
GO
TA
MIN
E-C
AF
FE
INE
OR
AL
YE
S
FR
OV
AT
RIP
TA
N S
UC
CIN
AT
EF
RO
VA
OR
AL
YE
S9
un
its
pe
r 3
0 d
ay
s
ISO
ME
TH
-D-C
HLO
RA
LPH
EN
AZ
-AP
AP
MID
RIN
OR
AL
YE
S
NA
RA
TR
IPT
AN
HC
L A
ME
RG
EO
RA
LY
ES
9 u
nit
s p
er
30
da
ys
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
8 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
AN
TIM
IGR
AIN
E P
RE
PA
RA
TIO
NS
(C
ON
T)
RIZ
AT
RIP
TA
N B
EN
ZO
AT
EM
AX
ALT
OR
AL
YE
S1
2 u
nit
s p
er
30
da
ys
RIZ
AT
RIP
TA
N B
EN
ZO
AT
EM
AX
ALT
MLT
OR
AL
YE
S1
2 u
nit
s p
er
30
da
ys
SU
MA
TR
IPT
AN
IM
ITR
EX
OR
AL
YE
S9
un
its
pe
r 3
0 d
ay
s
SU
MA
TR
IPT
AN
IM
ITR
EX
NA
SA
LY
ES
9 u
nit
s p
er
30
da
ys
SU
MA
TR
IPT
AN
IM
ITR
EX
SU
B-Q
YE
S9
un
its
pe
r 3
0 d
ay
s
SU
MA
TR
IPT
AN
-NA
PR
OX
EN
TR
EX
IME
TO
RA
LY
ES
9 u
nit
s p
er
30
da
ys
ZO
LMIT
RIP
TA
NZ
OM
IG 2
.5 M
GO
RA
LY
ES
12
un
its
pe
r 3
0 d
ay
s
ZO
LMIT
RIP
TA
NZ
OM
IG 5
.0 M
GO
RA
LY
ES
6 u
nit
s p
er
30
da
ys
ZO
LMIT
RIP
TA
NZ
OM
IGN
AS
AL
YE
S1
2 u
nit
s p
er
30
da
ys
ZO
LMIT
RIP
TA
NZ
OM
IG Z
MT
2.5
MG
OR
AL
YE
S1
2 u
nit
s p
er
30
da
ys
ZO
LMIT
RIP
TA
NZ
OM
IG Z
MT
5 M
GO
RA
LY
ES
6 u
nit
s p
er
30
da
ys
H7
WA
NT
I-N
AR
CO
LEP
SY
/AN
TI-
CA
TA
PLE
XY
SO
DIU
M O
XY
BA
TE
X
YR
EM
OR
AL
NO
H2
VA
NT
I-N
AR
CO
LEP
SY
/AN
TI-
HY
PE
RA
ll o
ral
form
ula
tio
ns
an
d s
tre
ng
ths
are
co
ve
red
fo
r a
llo
we
d c
on
dit
ion
s.
AR
MO
DA
FIN
ILN
UV
IGIL
OR
AL
YE
S
DE
XM
ET
HY
LPH
EN
IDA
TE
HC
LF
OC
ALI
NO
RA
LY
ES
ME
TH
YLP
HE
NID
AT
E H
CL
RIT
ALI
NO
RA
LY
ES
ME
TH
YLP
HE
NID
AT
E H
CL
CO
NC
ER
TA
OR
AL
YE
S
MO
DA
FIN
ILP
RO
VIG
ILO
RA
LY
ES
V1
MA
NT
INE
OP
L IM
MU
NO
DU
LAT
OR
AG
T
LEN
ALI
DO
MID
E
RE
VLI
MID
OR
AL
NO
V3
FA
NT
INE
OP
LAS
TIC
-AR
OM
AT
AS
E I
NH
IB
AN
AS
TR
OZ
OLE
AR
IMID
EX
OR
AL
NO
EX
EM
ES
TA
NE
A
RO
MA
SIN
OR
AL
NO
LET
RO
ZO
LEF
EM
AR
AO
RA
LN
O
Z1
EA
NT
IOX
IDA
NT
AG
EN
TS
LUT
EIN
-ZE
AX
AN
TH
IN
LUT
EIN
OR
AL
NO
H6
BA
NT
IPA
RK
INS
ON
ISM
DR
UG
S,
AN
TI
BE
NZ
TR
OP
INE
ME
SY
LAT
EC
OG
EN
TIN
OR
AL
YE
S
TR
IHE
XY
PH
EN
IDY
L H
CL
AR
TA
NE
OR
AL
YE
S
H6
AA
NT
IPA
RK
INS
ON
ISM
DR
UG
S,
OT
HE
AM
AN
TA
DIN
E H
CL
SY
MM
ET
RE
LO
RA
LY
ES
BR
OM
OC
RIP
TIN
E M
ES
YLA
TE
PA
RLO
DE
LO
RA
LY
ES
CA
RB
IDO
PA
-LE
VO
DO
PA
SIN
EM
ET
OR
AL
YE
S
CA
RB
IDO
PA
-LE
VO
DO
PA
-EN
TA
CA
PO
NE
S
TA
LEV
O 1
50
OR
AL
YE
S
EN
TA
CA
PO
NE
CO
MT
AN
OR
AL
YE
S
PE
RG
OLI
DE
ME
SY
LAT
EP
ER
MA
XO
RA
LY
ES
PR
AM
IPE
XO
LE D
IHY
DR
OC
HLO
RID
EM
IRA
PE
XO
RA
LY
ES
RA
SA
GIL
INE
ME
SY
LAT
EA
ZIL
EC
TO
RA
LY
ES
RO
PIN
IRO
LE H
CL
RO
PIN
IRO
LE H
CL
OR
AL
YE
S
RO
PIN
IRO
LE H
YD
RO
CH
LOR
IDE
RE
QU
IPO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
9 o
f 4
2
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
L8B
AN
TIP
ER
SP
IRA
NT
S
ALU
MIN
UM
CH
LOR
IDE
D
RY
SO
LT
OP
ICA
LN
O
L3P
AN
TIP
RU
RIT
ICS
, T
OP
ICA
L
DIP
HE
NH
YD
RA
MIN
E H
CL
BE
NA
DR
YL
ITC
H S
TO
PP
ING
TO
PIC
AL
NO
DO
XE
PIN
HC
LP
RU
DO
XIN
TO
PIC
AL
NO
PR
AM
OX
INE
-BE
NZ
YL
ALC
OH
OL
ITC
H-X
TO
PIC
AL
NO
PR
AM
OX
INE
-ZIN
C A
CE
TA
TE
C
ALA
DR
YL
CLE
AR
TO
PIC
AL
NO
L1A
AN
TIP
SO
RIA
TIC
AG
EN
T S
YS
TE
MIC
AC
ITR
ET
INS
OR
IAT
AN
EO
RA
LY
ES
L5F
AN
TIP
SO
RIA
TIC
S A
GE
NT
S
CA
LCIP
OT
RIE
NE
DO
VO
NE
XT
OP
ICA
LY
ES
TA
ZA
RO
TE
NE
TA
ZO
RA
CT
OP
ICA
LY
ES
H7
TA
NT
IPS
YC
HO
TIC
-AT
YP
ICA
L A
NT
AG
ON
AS
EN
AP
INE
MA
LEA
TE
SA
PH
RIS
SU
BLI
NG
UA
LN
O
CLO
ZA
PIN
EC
LOZ
AR
ILO
RA
LN
O
OLA
NZ
AP
INE
ZY
PR
EX
AO
RA
LN
O
PA
LIP
ER
IDO
NE
IN
VE
GA
OR
AL
NO
QU
ET
IAP
INE
FU
MA
RA
TE
S
ER
OQ
UE
LO
RA
LN
O
RIS
PE
RID
ON
ER
ISP
ER
DA
LO
RA
LN
O
ZIP
RA
SID
ON
E H
CL
GE
OD
ON
OR
AL
NO
H7
OA
NT
IPS
YC
HO
TIC
-BU
TY
RO
NP
HE
NO
NE
S
HA
LOP
ER
IDO
L H
ALD
OL
OR
AL
NO
H7
SA
NT
IPS
YC
HO
TIC
-DIH
YD
RO
IND
OLO
NE
S
MO
LIN
DO
NE
HC
L M
OB
AN
OR
AL
NO
H7
RA
NT
IPS
YC
HO
TIC
-DIP
HE
NY
LBU
TY
LPIP
PIM
OZ
IDE
O
RA
PO
RA
LN
O
H7
UA
NT
IPS
YC
HO
TIC
-DO
PA
/SE
RO
AN
TG
LOX
AP
INE
SU
CC
INA
TE
LO
XIT
AN
EO
RA
LN
O
H2
GA
NT
I-P
SY
CH
OT
ICS
,PH
EN
OT
HIA
ZIN
CH
LOR
PR
OM
AZ
INE
HC
LT
HO
RA
ZIN
EO
RA
LN
O
FLU
PH
EN
AZ
INE
HC
LP
RO
LIX
INO
RA
LN
O
PE
RP
HE
NA
ZIN
ET
RIL
AF
ON
OR
AL
NO
TH
IOR
IDA
ZIN
E H
CL
ME
LLA
RIL
OR
AL
NO
TR
IFLU
OP
ER
AZ
INE
HC
LS
TE
LAZ
INE
OR
AL
NO
H7
XA
NT
IPS
YC
HO
TIC
S-A
TY
PIC
AL,
D2
/5H
T
AR
IPIP
RA
ZO
LE
AB
ILIF
YO
RA
LN
O
H7
PA
NT
IPS
YC
HO
TIC
-TH
IOX
AN
TH
EN
ES
TH
IOT
HIX
EN
E
NA
VA
NE
OR
AL
NO
W2
EA
NT
ITU
BE
RC
ULA
R A
GE
NT
S
ET
HA
MB
UT
OL
HC
LE
TH
AM
BU
TO
L H
CL
OR
AL
NO
ISO
NIA
ZID
IS
ON
IAZ
IDO
RA
LN
O
PY
RA
ZIN
AM
IDE
P
YR
AZ
INA
MID
EO
RA
LN
O
RIF
AB
UT
INM
YC
OB
UT
INO
RA
LN
O
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
10
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
W1
GA
NT
ITU
BE
RC
ULA
R A
NT
IBIO
TIC
S
RIF
AM
PIN
RIF
AD
INO
RA
LN
O
B3
SA
NT
ITU
SS
-AN
TIH
IST
-DE
CO
NG
-EX
PE
C
PH
EN
YLE
PH
-CH
LOR
PH
EN
W/
DM
-GG
Q
UA
L-T
US
SIN
OR
AL
NO
B3
TA
NT
ITU
SS
-EX
PE
CT
OR
AN
T-C
OM
BIN
AT
I
DE
XT
RO
ME
TH
OR
PH
AN
-GU
AIF
EN
ES
IN S
YR
UP
RO
BIT
US
SIN
-DM
CO
UG
HO
RA
LN
O
H6
CA
NT
ITU
SS
IVE
, N
ON
-NA
RC
OT
IC
BE
NZ
ON
AT
AT
ET
ES
SA
LON
OR
AL
NO
DE
XT
RO
ME
TH
OR
PH
AN
PO
LIS
TIR
EX
D
ELS
YM
OR
AL
NO
B3
RA
NT
ITU
SS
IVE
-AN
TIH
IST
-DE
CO
NG
ES
TB
RO
MP
HE
NIR
AM
INE
&
DE
XT
RO
ME
TH
OR
PH
AN
BR
OM
FE
D-D
MO
RA
LN
OP
HE
NY
LEP
H T
AN
-PY
RIL
AM
INE
TA
N-C
AR
BE
TA
TA
N T
AB
TU
SS
I-1
2D
OR
AL
NO
PH
EN
YLE
PH
-EP
HE
D-C
PM
W/
CA
RB
ET
AP
EN
TA
NE
R
YN
AT
US
SO
RA
LN
O
PH
EN
YLE
PH
RIN
E-C
HLO
RP
HE
N-D
M
C-P
HE
N D
MO
RA
LN
O
PH
EN
YLE
PH
RIN
E-P
YR
ILA
MIN
E-D
MC
OD
AL-
DM
OR
AL
NO
PS
EU
DO
EP
H-B
RO
MP
HE
N W
/
HY
DR
OC
OD
ON
E S
OLN
B
RO
MP
LEX
DM
OR
AL
NO
PS
EU
DO
EP
HE
D T
AN
-BR
OM
PH
EN
TA
N-D
M
TA
N S
US
PA
NA
PLE
X D
MX
OR
AL
NO
PS
EU
DO
EP
HE
D-B
RO
MP
HE
N-D
M S
YR
UP
BR
OM
ET
AN
E D
XO
RA
LN
O
PS
EU
DO
EP
HE
D-B
RO
MP
HE
NP
HE
NIR
AM
INE
PS
E B
RO
MO
RA
LN
O
D4
FA
NT
IULC
ER
H P
YLO
RI
AG
EN
TS
AM
OX
ICIL
LIN
CA
P-C
LAR
ITH
RO
TA
B-
LAN
SO
PR
AZ
P
RE
VP
AC
OR
AL
YE
SM
ET
RO
NID
AZ
TA
B-T
ET
RA
CY
C C
AP
-BIS
SU
BS
AL
HE
LID
AC
OR
AL
YE
S
D4
EA
NT
IULC
ER
PR
EP
AR
AT
ION
S
MIS
OP
RO
ST
OL
CY
TO
TE
CO
RA
LN
O
SU
CR
ALF
AT
E
CA
RA
FA
TE
OR
AL
NO
W5
HA
NT
IVIR
AL
GE
NE
RA
L C
ON
T.
1
VA
LGA
NC
ICLO
VIR
HC
LV
ALC
YT
EO
RA
LY
ES
W5
AA
NT
IVIR
ALS
AC
YC
LOV
IRA
CY
CLO
VIR
OR
AL
YE
S
FA
MC
ICLO
VIR
FA
MV
IRO
RA
LY
ES
OS
ELT
AM
IVIR
PH
OS
PH
AT
E
TA
MIF
LUO
RA
LY
ES
VA
LAC
YC
LOV
IR H
CL
VA
LTR
EX
OR
AL
YE
S
C7
FA
PP
ET
ITE
ST
IMU
LAN
TS
AN
OR
EX
IA
ME
GE
ST
RO
L A
CE
TA
TE
M
EG
AC
EO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
11
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
Q6
TA
RT
IFIC
IAL
TE
AR
S
AR
TIF
ICIA
L T
EA
RS
AK
WA
TE
AR
SO
PH
TH
ALM
ICN
O
AR
TIF
ICIA
L T
EA
RS
LAC
RIS
ER
TO
PH
TH
ALM
ICN
O
AR
TIF
ICIA
L T
EA
RS
N
AT
UR
E'S
TE
AR
SO
PH
TH
ALM
ICN
O
CA
RB
OX
YM
ET
HY
LCE
LLU
LOS
E S
OD
IUM
RE
FR
ES
H P
LUS
OP
HT
HA
LMIC
NO
CA
RB
OX
YM
ET
HY
LCE
LLU
LOS
E-G
LYC
ER
INO
PT
IVE
OP
HT
HA
LMIC
NO
GLY
CE
RIN
-PO
LYS
OR
BA
TE
80
RE
FR
ES
H D
RY
EY
E T
HE
RA
PY
OP
HT
HA
LMIC
NO
HY
PR
OM
ELL
OS
EG
EN
TE
AL
OP
HT
HA
LMIC
NO
HY
PR
OM
ELL
OS
EIS
OP
TO
TE
AR
SO
PH
TH
ALM
ICN
O
Ina
ctiv
eR
EF
RE
SH
LIQ
UIG
EL
OP
HT
HA
LMIC
NO
PO
LYE
TH
YLE
NE
GLY
CO
L-P
OLY
VIN
YL
ALC
OH
OL
HY
PO
TE
AR
SO
PH
TH
ALM
ICN
O
PO
LYE
TH
YLE
NE
GLY
CO
L-P
RO
PY
LEN
E G
LYC
OL
SY
ST
AN
EO
PH
TH
ALM
ICN
O
PO
LYV
INY
L A
LCO
HO
L T
EA
RG
EN
OP
HT
HA
LMIC
NO
PO
LYV
INY
L A
LCO
HO
L-P
OV
IDO
NE
R
EF
RE
SH
OP
HT
HA
LMIC
NO
PO
LYV
INY
L A
LC-P
OV
IDO
NE
-2,4
-D
DIM
ET
HY
LAM
INE
FR
ES
HK
OT
EO
PH
TH
ALM
ICN
O
L4A
AS
TR
ING
EN
TS
ALU
MIN
UM
AC
ET
AT
EA
-MA
NT
LET
OP
ICA
LN
O
ALU
MIN
UM
AC
ET
AT
E S
OLN
ALU
MIN
UM
AC
ET
AT
E S
OLN
TO
PIC
AL
NO
WIT
CH
HA
ZE
L (H
AM
AM
ELI
S V
IRG
INIA
NA
)T
UC
KS
TO
PIC
AL
NO
WIT
CH
HA
ZE
L-G
LYC
ER
IN
ME
DI
PA
DS
TO
PIC
AL
NO
H2
DB
AR
BIT
UR
AT
ES
BU
TIS
OL
SO
DIU
MB
UT
ISO
L S
OD
IUM
OR
AL
YE
S
PH
EN
OB
AR
BIT
AL
PH
EN
OB
AR
BIT
AL
OR
AL
YE
S
SE
CO
BA
RB
ITA
L S
OD
IUM
S
EC
ON
AL
SO
DIU
MO
RA
LY
ES
J2A
BE
LLA
DO
NN
A A
LKA
LOID
S
AT
RO
PIN
E S
ULF
AT
E
SA
L-T
RO
PIN
EO
RA
LN
O
BE
LLA
DO
NN
A A
LKA
LOID
S-P
HE
NO
BA
RB
ITA
L D
ON
NA
TA
LO
RA
LN
O
HY
OS
CY
AM
INE
SU
LFA
TE
LE
VS
INO
RA
LN
O
ME
TH
SC
OP
OLA
MIN
E B
RO
MID
E
PA
MIN
EO
RA
LN
O
Q9
BB
EN
IGN
PR
OS
TA
TIC
HY
PE
RT
RO
PH
Y
ALF
UZ
OS
IN H
CL
UR
OX
AT
RA
LO
RA
LY
ES
DU
TA
ST
ER
IDE
AV
OD
AR
TO
RA
LY
ES
FIN
AS
TE
RID
EF
INA
ST
ER
IDE
OR
AL
YE
S
SIL
OD
OS
IN
RA
PA
FLO
OR
AL
YE
S
TA
MS
ULO
SIN
HC
LF
LOM
AX
OR
AL
YE
S
J7C
BE
TA
AD
RE
NE
RG
IC B
LOC
KIN
G A
GE
S
AC
EB
UT
OLO
L H
CL
AC
EB
UT
OLO
L H
CL
OR
AL
YE
S
AT
EN
OLO
LT
EN
OR
MIN
OR
AL
YE
S
BIS
OP
RO
LOL
FU
MA
RA
TE
BIS
OP
RO
LOL
FU
MA
RA
TE
OR
AL
YE
S
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
12
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
BE
TA
AD
RE
NE
RG
IC B
LOC
KIN
G A
GE
S (
CO
NT
)M
ET
OP
RO
LOL
SU
CC
INA
TE
TO
PR
OL
XL
OR
AL
YE
S
ME
TO
PR
OLO
L T
AR
TR
AT
ELO
PR
ES
SO
RO
RA
LY
ES
NA
DO
LOL
CO
RG
AR
DO
RA
LY
ES
PIN
DO
LOL
PIN
DO
LOL
OR
AL
YE
S
PR
OP
RA
NO
LOL
HC
L IN
DE
RA
LO
RA
LY
ES
SO
TA
LOL
SO
TA
LOL
OR
AL
YE
S
TIM
OLO
L M
ALE
AT
ET
IMO
LOL
MA
LEA
TE
OR
AL
YE
S
J7D
BE
TA
AD
RE
NE
RG
IC B
LOC
KIN
G C
ON
NE
BIV
OLO
L H
CL
BY
ST
OLI
CO
RA
LN
O
J5D
BE
TA
-AD
RE
NE
RG
IC A
GE
NT
S
ALB
UT
ER
OL
SU
LFA
TE
ALB
UT
ER
OL
INH
ALA
TIO
NN
O
ALB
UT
ER
OL
SU
LFA
TE
PR
OV
EN
TIL
OR
AL
NO
AR
FO
RM
OT
ER
OL
TA
RT
RA
TE
B
RO
VA
NA
INH
ALA
TIO
NN
O
FO
RM
OT
ER
OL
FU
MA
RA
TE
F
OR
AD
ILIN
HA
LAT
ION
NO
LEV
ALB
UT
ER
OL
HC
LX
OP
EN
EX
INH
ALA
TIO
NN
O
ME
TA
PR
OT
ER
EN
OL
SU
LFA
TE
ME
TA
PR
EL
OR
AL
NO
ME
TA
PR
OT
ER
EN
OL
SU
LFA
TE
ME
TA
PR
EL
INH
ALA
TIO
NN
O
PIR
BU
TE
RO
L A
CE
TA
TE
MA
XA
IR A
UT
OH
ALE
RIN
HA
LAT
ION
NO
SA
LME
TE
RO
L X
INA
FO
AT
ES
ER
EV
EN
T D
ISK
US
INH
ALA
TIO
NN
O
TE
RB
UT
ALI
NE
SU
LFA
TE
BR
ET
HIN
EO
RA
LN
O
J5J
BE
TA
-AD
RE
NE
RG
IC/A
NT
ICH
OLI
N C
MB
IPR
AT
RO
PIU
M-A
LBU
TE
RO
L C
OM
BIV
EN
TIN
HA
LAT
ION
NO
J5G
BE
TA
-AD
RE
NE
RG
ICS
GLU
CO
CO
RT
ICB
UD
ES
ON
IDE
-FO
RM
OT
ER
OL
FU
MA
RA
TE
DIH
YD
SY
MB
ICO
RT
INH
ALA
TIO
NN
O
FLU
TIC
AS
ON
E-S
ALM
ET
ER
OL
AD
VA
IR
INH
ALA
TIO
NN
OM
OM
ET
AS
ON
E F
UR
OA
TE
-FO
RM
OT
ER
OL
FU
MA
RA
TE
DU
LER
AIN
HA
LAT
ION
NO
J7H
BE
TA
-BLO
CK
ER
/TH
IAZ
IDE
CO
MB
O
AT
EN
OLO
L-C
HLO
RT
HA
LID
ON
EA
TE
NO
LOL-
CH
LOR
TH
ALI
DO
NE
OR
AL
NO
BIS
OP
RO
LOL
& H
YD
RO
CH
LOR
OT
HIA
ZID
EZ
IAC
OR
AL
NO
BIS
OP
RO
LOL
FU
MA
RA
TE
-HC
TZ
BIS
OP
RO
LOL
FU
MA
RA
TE
-HC
TZ
OR
AL
NO
ME
TO
PR
OLO
L-H
YD
RO
CH
LOR
OT
HIA
ZID
EM
ET
OP
RO
LOL-
HY
DR
OC
HLO
RO
TH
IAZ
IDE
OR
AL
NO
D7
LB
ILE
SA
LT I
NH
IBIT
OR
S
CH
OLE
ST
YR
AM
INE
PR
EV
ALI
TE
OR
AL
YE
S
CO
LES
EV
ELA
M H
CL
WE
LCH
OL
OR
AL
YE
S
CO
LES
TIP
OL
HC
L C
OLE
ST
IDO
RA
LY
ES
D7
AB
ILE
SA
LTS
UR
SO
DIO
L U
RS
O F
OR
TE
OR
AL
YE
S
P4
BB
ON
E F
OR
M S
TIM
AG
TS
-PT
HO
RM
O
TE
RIP
AR
AT
IDE
(R
EC
OM
BIN
AN
T)
FO
RT
EO
SU
B-Q
YE
S
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
13
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
P4
LB
ON
E O
SS
IFIC
AT
ION
SU
PP
RE
SS
IO
ALE
ND
RO
NA
TE
SO
DIU
MF
OS
AM
AX
OR
AL
YE
S
CA
LCIT
ON
IN (
SA
LMO
N)
MIA
CA
LCIN
NA
SA
LY
ES
ET
IDR
ON
AT
E D
ISO
DIU
ME
TID
RO
NA
TE
DIS
OD
IUM
OR
AL
YE
S
IBA
ND
RO
NA
TE
SO
DIU
M
BO
NIV
AO
RA
LY
ES
RA
LOX
IFE
NE
HC
L E
VIS
TA
OR
AL
YE
S
RIS
ED
RO
NA
TE
SO
DIU
MA
CT
ON
EL
OR
AL
YE
S
P4
OB
ON
E R
ES
OR
P I
NH
IB-C
ALC
IUM
CO
MR
ISE
DR
ON
AT
E S
OD
WIT
H C
ALC
IUM
CA
RB
ON
AT
EA
CT
ON
EL
WIT
H C
ALC
IUM
OR
AL
YE
S
P4
NB
ON
E R
ES
OR
PT
ION
IN
HIB
& V
IT D
ALE
ND
RO
NA
TE
SO
DIU
M-C
HO
LEC
ALC
IFE
RO
L F
OS
AM
AX
PLU
S D
OR
AL
YE
S
P4
MB
ON
E R
I, S
EN
SIT
IVIT
Y E
NH
AN
CE
R
CIN
AC
ALC
ET
HC
L S
EN
SIP
AR
OR
AL
YE
S
C6
SC
6S
VIT
AM
IN B
& C
CO
MB
INA
TIO
N
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
MU
LTIP
LE V
ITA
MIN
S W
/ M
INE
RA
LST
HE
RA
PE
UT
IC-M
OR
AL
NO
C6
VC
6V
PR
NT
L V
ITA
MIN
PR
EP
S(C
ON
T1
)
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
PR
EN
AT
AL
VIT
W/
DS
S-I
RO
N C
AR
BO
NY
L-F
A
ULT
RA
NA
TA
LCA
RE
OR
AL
YE
S
A9
AC
ALC
IUM
CH
AN
NE
L B
LOC
KIN
G A
GT
AM
LOD
IPIN
E B
ES
YLA
TE
NO
RV
AS
CO
RA
LY
ES
DIL
TIA
ZE
M H
CL
CA
RD
IZE
M
OR
AL
YE
S
FE
LOD
IPIN
EF
ELO
DIP
INE
ER
OR
AL
YE
S
ISR
AD
IPIN
ED
YN
AC
IRC
CR
OR
AL
YE
S
NIC
AR
DIP
INE
HC
LC
AR
DE
NE
O
RA
LY
ES
NIF
ED
IPIN
EP
RO
CA
RD
IAO
RA
LY
ES
NIS
OLD
IPIN
ES
ULA
RO
RA
LY
ES
VE
RA
PA
MIL
HC
L V
ER
ELA
NO
RA
LY
ES
C1
FC
ALC
IUM
RE
PLA
CE
ME
NT
All
ca
lciu
m s
alt
s a
nd
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d c
on
dit
ion
s
CA
LCIU
M C
AR
BO
NA
TE
-VIT
AM
IN D
CA
LCIU
M 5
00
+ V
IT D
OR
AL
YE
S
CA
LCIU
M C
ITR
AT
E-V
ITA
MIN
DC
ALC
ITR
AT
EO
RA
LY
ES
CA
LCIU
M G
LUC
ON
AT
E
CA
LCIU
M G
LUC
ON
AT
EO
RA
LY
ES
CA
LCIU
M W
/ M
AG
NE
SIU
MC
ALC
IUM
-MA
GN
ES
IUM
OR
AL
YE
S
R1
EC
AR
BO
NIC
AN
HY
DR
AS
E I
NH
IBIT
OR
AC
ET
AZ
OLA
MID
EA
CE
TA
ZO
LAM
IDE
OR
AL
YE
S
ME
TH
AZ
OLA
MID
EM
ET
HA
ZO
LAM
IDE
OR
AL
YE
S
W1
WC
EP
HA
LOS
PR
OR
IN,
1S
T G
EN
ER
AT
CE
FA
DR
OX
ILC
EF
AD
RO
XIL
OR
AL
NO
CE
PH
ALE
XIN
KE
FLE
XO
RA
LN
O
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
14
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
W1
XC
EP
HA
LOS
PR
OR
IN,
2N
D G
EN
ER
AT
CE
FA
CLO
R
CE
FA
CLO
RO
RA
LN
O
CE
FP
RO
ZIL
CE
FP
RO
ZIL
OR
AL
NO
CE
FU
RO
XIM
E A
XE
TIL
CE
FT
INO
RA
LN
O
W1
YC
EP
HA
LOS
PR
OR
IN,
3R
D G
EN
ER
AT
CE
FD
INIR
O
MN
ICE
FO
RA
LN
O
CE
FD
ITO
RE
N P
IVO
XIL
S
PE
CT
RA
CE
FO
RA
LN
O
CE
FIX
IME
SU
PR
AX
OR
AL
NO
CE
FT
AZ
IDIM
EC
EF
TA
ZID
IME
INJE
CT
ION
NO
CE
FT
IBU
TE
N
CE
DA
XO
RA
LN
O
CE
FT
RIA
XO
NE
CE
FT
RIA
XO
NE
INJE
CT
ION
NO
W1
ZC
EP
HA
LOS
PR
OR
IN,
4T
H G
EN
ER
AT
CE
FE
PIM
E H
CL
CE
FE
PIM
EIN
TR
AV
EN
NO
CE
FE
PIM
E H
CL
CE
FE
PIM
E H
CL
INJE
CT
ION
NO
J1B
CH
OLI
NE
ST
ER
AS
E I
NH
IBIT
OR
S
DO
NE
PE
ZIL
HY
DR
OC
HLO
RID
EA
RIC
EP
TO
RA
LY
ES
GA
LAN
TA
MIN
E H
YD
RO
BR
OM
IDE
RA
ZA
DY
NE
OR
AL
YE
S
PY
RID
OS
TIG
MIN
E B
RO
MID
EM
ES
TIN
ON
OR
AL
YE
S
RIV
AS
TIG
MIN
E T
AR
TR
AT
E
EX
ELO
NO
RA
LY
ES
Z2
FC
HR
OM
OLY
N A
ND
DE
RIV
AT
IVE
S
CR
OM
OLY
N S
OD
IUM
CR
OM
OLY
N S
OD
IUM
INH
ALA
TIO
NN
O
D6
FC
HR
ON
IC C
OLO
N I
NF
LAM
DR
UG
TX
BA
LSA
LAZ
IDE
DIS
OD
IUM
BA
LSA
LAZ
IDE
DIS
OD
IUM
O
RA
LY
ES
ME
SA
LAM
INE
A
SA
CO
LO
RA
LY
ES
OLS
ALA
ZIN
E S
OD
IUM
D
IPE
NT
UM
OR
AL
YE
S
S2
AC
OLC
HIC
INE
CO
LCH
ICIN
EC
OLC
HIC
INE
OR
AL
YE
S
Q3
EC
OLO
N I
NF
LAM
DR
UG
, R
EC
TA
L
ME
SA
LAM
INE
C
AN
AS
AR
EC
TA
LY
ES
A7
BC
OR
ON
AR
Y V
AS
OD
ILA
TO
RS
ISO
SO
RB
IDE
DIN
ITR
AT
EIS
OS
OR
BID
E D
INIT
RA
TE
OR
AL
YE
S
ISO
SO
RB
IDE
MO
NO
NIT
RA
TE
ISM
OO
RA
LY
ES
NIT
RO
GLY
CE
RIN
NIT
RO
GLY
CE
RIN
OR
AL
YE
S
NIT
RO
GLY
CE
RIN
OIN
T 2
%
NIT
RO
-BID
OIN
TT
RA
NS
DE
RM
YE
S
NIT
RO
GLY
CE
RIN
PA
TC
HN
ITR
OG
LYC
ER
IN P
AT
CH
TR
AN
SD
ER
MY
ES
NIT
RO
GLY
CE
RIN
SL
NIT
RO
ST
AT
SU
BLI
NG
UA
LY
ES
NIT
RO
GLY
CE
RIN
TL
SO
LNN
ITR
OLI
NG
UA
LT
RA
NS
LIN
GY
ES
B4
TD
EC
ON
GE
ST
-AN
ALG
ES
IC,N
ON
-SA
LIC
YLA
TE
CO
MB
.
PH
EN
YLE
PH
RIN
E W
/ A
CE
TA
MIN
OP
HE
NP
HE
NY
LEP
HR
INE
W/
AC
ET
AM
INO
PH
EN
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
15
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
B4
WD
EC
ON
GE
ST
AN
T-E
XP
EC
TO
RA
NT
CO
MB
PH
EN
YLE
PH
RIN
E-G
UA
IFE
NE
SIN
CA
P S
R
GE
NE
XA
LA
OR
AL
NO
PS
EU
DO
EP
HE
DR
INE
-GU
AIF
EN
ES
IN T
AB
SR
M
UC
INE
X D
OR
AL
NO
B4
UD
EC
ON
GE
ST
-AN
TIC
HO
LIN
ER
GIC
CM
BP
SE
UD
OE
PH
ED
RIN
E-M
ET
HS
CO
PO
LAM
INE
TA
B
PS
EU
DO
EP
HE
DR
INE
-ME
TH
SC
OP
OLA
MIN
E
TA
BO
RA
LN
O
D1
DD
EN
TA
L A
IDS
AN
D P
RE
PA
RA
TIO
NS
CH
LOR
HE
XID
INE
GLU
CO
NA
TE
P
ER
IOG
AR
DM
UC
OU
S M
EM
YE
S
TR
IAM
CIN
OLO
NE
AC
ET
ON
IDE
T
RIA
MC
INO
LON
E A
CE
TO
NID
ED
EN
TA
LY
ES
L8A
DE
OD
OR
AN
TS
OS
TO
MY
SU
PP
LIE
SM
9M
ISC
ELL
NO
L0C
DIA
BE
TIC
ULS
ER
PR
EP
TO
PIC
AL
BE
CA
PLE
RM
IN
RE
GR
AN
EX
TO
PIC
AL
YE
S
A1
AD
IGIT
ALI
S G
LYC
OS
IDE
S
DIG
OX
INLA
NO
XIN
Ora
lY
ES
F2
AD
RU
GS
TO
TR
EA
T I
MP
OT
EN
CY
ALP
RO
ST
AD
IL
CA
VE
RJE
CT
INT
RA
CA
VE
RY
ES
6 U
NIT
S P
ER
30
DA
YS
ALP
RO
ST
AD
IL
ED
EX
INT
RA
CA
VE
RY
ES
6 U
NIT
S P
ER
30
DA
YS
ALP
RO
ST
AD
IL U
RE
TH
RA
L P
ELL
ET
MU
SE
UR
ET
HR
AL
YE
S6
UN
ITS
PE
R 3
0 D
AY
S
SIL
DE
NA
FIL
CIT
RA
TE
VIA
GR
AO
RA
LY
ES
6 U
NIT
S P
ER
30
DA
YS
TA
DA
LAF
ILC
IALI
SO
RA
LY
ES
10
mg
or
20
mg
= 6
Un
its
pe
r 3
0 d
ay
s,
2.5
mg
or
5m
g =
30
un
its
pe
r 3
0 d
ay
s
VA
RD
EN
AF
IL H
CL
LEV
ITR
AO
RA
LY
ES
6 U
NIT
S P
ER
30
DA
YS
YO
HIM
BIN
E H
CL
YO
HIM
BIN
E H
CL
OR
AL
YE
SP
A r
eq
uir
ed
bu
t n
o m
on
thly
qu
an
tity
re
stri
ctio
ns
Q8
WE
AR
PR
EP
S A
NT
IBIO
TIC
S
Ina
ctiv
eA
NT
IBIO
TIC
EA
R S
US
PE
NS
ION
OT
ICN
O
Ina
ctiv
eF
LOX
INO
TIC
NO
NE
OM
YC
IN-C
OLI
ST
IN-H
C-T
HO
NZ
ON
IUM
C
OR
TIS
PO
RIN
-TC
OT
ICN
O
NE
OM
YC
IN-P
OLY
MY
XIN
-HC
CO
RT
OM
YC
INO
TIC
NO
OF
LOX
AC
IN
OF
LOX
AC
INO
TIC
NO
Q8
PE
AR
PR
EP
S A
NT
IIN
FLA
MM
AT
OR
Y
FLU
OC
INO
LON
E A
CE
TO
NID
ED
ER
MO
TIC
OT
ICN
O
Q8
HE
AR
PR
EP
S L
OC
AL
AN
ES
TH
ET
IC
AC
ET
IC A
CID
-AN
TIP
YR
INE
-
BE
NZ
OC
AIN
E-P
OLY
CO
SA
NO
LA
CE
TIC
AC
ID-A
NT
IPY
RIN
E-B
EN
ZO
CA
IO
TIC
NO
AN
TIP
YR
INE
-BE
NZ
OC
AIN
E-P
OLY
CO
SA
NO
LA
UR
ALG
AN
OT
ICN
O
BE
NZ
OC
AIN
E-A
NT
IPY
RIN
E
AU
RO
DE
X E
AR
DR
OP
SO
TIC
NO
Q8
BE
AR
PR
EP
S M
ISC
AN
TII
NF
EC
TIV
E
AC
ET
IC A
CID
AC
ET
IC A
CID
OT
ICN
O
AC
ET
IC A
CID
-ALU
MIN
UM
AC
ET
IC A
CID
-ALU
MIN
UM
OT
ICN
O
AC
ET
IC A
CID
-HY
DR
OC
OR
TIS
ON
EA
CE
TIC
AC
ID-H
YD
RO
CO
RT
ISO
NE
OT
ICN
O
CR
ES
YL
AC
ET
AT
EC
RE
SY
LAT
EO
TIC
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
16
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
EA
R P
RE
PS
MIS
C A
NT
IIN
FE
CT
IVE
CO
NT
HY
DR
OC
OR
TIS
ON
E W
/ A
CE
TIC
AC
ID
AC
ET
AS
OL
HC
OT
ICN
O
PR
AM
OX
INE
-HC
-CH
LOR
OX
YLE
NO
L
P
RA
MO
XIN
E-H
C-C
HLO
RO
XY
LEN
OL
OT
IC S
OLN
O
TIC
NO
Q8
YE
AR
PR
EP
S M
ISC
OT
C O
NLY
Ina
ctiv
eS
TA
R-O
TIC
OT
ICN
O
C1
AE
LEC
TR
OLY
TE
DE
PLE
TE
RS
CA
LCIU
M A
CE
TA
TE
(P
HO
SP
HA
TE
BIN
DE
R)
PH
OS
LOO
RA
LY
ES
LAN
TH
AN
UM
CA
RB
ON
AT
EF
OS
RE
NO
LO
RA
LY
ES
SE
VE
LAM
ER
CA
RB
ON
AT
ER
EN
VE
LAO
RA
LY
ES
SE
VE
LAM
ER
HC
L R
EN
AG
EL
OR
AL
YE
S
SO
DIU
M P
OLY
ST
YR
EN
E S
ULF
ON
AT
EK
AY
EX
ALA
TE
OR
AL
YE
S
C1
ZE
LEC
TR
OLY
TE
RE
PLA
CE
ME
NT
SA
LIV
A S
UB
ST
ITU
TE
SA
LIV
A S
UB
ST
ITU
TE
MU
CO
US
ME
MN
O
L2A
EM
OLL
IEN
TS
ALO
E V
ER
AA
LOE
VE
RA
TO
PIC
AL
NO
AM
MO
NIU
M L
AC
TA
TE
AM
MO
NIU
M L
AC
TA
TE
TO
PIC
AL
NO
BA
BY
OIL
BA
BY
OIL
TO
PIC
AL
NO
DE
RM
AT
OLO
GIC
AL
PR
OD
UC
TS
MIS
CX
CLA
IRT
OP
ICA
LN
O
EM
OLL
IEN
TN
IVE
AT
OP
ICA
LN
O
EM
OLL
IEN
TS
HE
PA
RD
'S S
KIN
CR
EA
MT
OP
ICA
LN
O
LAC
TIC
AC
ID (
AM
MO
NIU
M L
AC
TA
TE
)LA
C-H
YD
RIN
TO
PIC
AL
NO
LAN
OLI
NLA
NO
LIN
TO
PIC
AL
NO
NE
OM
YC
IN-P
OLY
MY
XIN
B-G
RA
MIC
IDIN
N
EO
SP
OR
INT
OP
ICA
LN
O
SA
LIN
E N
AS
AL
AY
R S
ALI
NE
TO
PIC
AL
NO
SC
AR
TR
EA
TM
EN
T P
RO
DU
CT
SM
ED
ER
MA
TO
PIC
AL
NO
SK
IN P
RO
TE
CT
AN
TS
MIS
CE
UC
ER
INT
OP
ICA
LN
O
TR
OLA
MIN
E S
ALI
CY
LAT
E
AS
PE
RC
RE
ME
TO
PIC
AL
NO
VIT
AM
INS
A &
DV
ITA
MIN
A &
DT
OP
ICA
LN
O
L2B
EM
OLL
IEN
TS
(C
ON
T 1
)
EM
OLL
IEN
TE
LET
ON
ET
OP
ICA
LN
O
WO
UN
D D
RE
SS
ING
SB
IAF
INE
TO
PIC
AL
NO
L2C
EM
OLL
IEN
TS
(C
ON
TIN
UE
D 2
)
DE
RM
AT
OLO
GIC
AL
PR
OD
UC
TS
MIS
CE
PIC
ER
AM
TO
PIC
AL
NO
EM
OLL
IEN
TM
IMY
XT
OP
ICA
LN
O
SK
IN P
RO
TE
CT
AN
TS
MIS
C
EU
CE
RIN
TO
PIC
AL
NO
G1
AE
ST
RO
GE
NIC
AG
EN
TS
ES
TR
AD
IOL
ES
TR
AD
IOL
OR
AL
YE
S
W7
BE
XA
NT
HE
MA
TO
US
AN
D T
UM
OR
CA
U
ZO
ST
ER
VA
CC
INE
LIV
E
ZO
ST
AV
AX
SU
B-Q
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
17
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
B3
JE
XP
EC
TO
RA
NT
S
GU
AIF
EN
ES
INR
OB
ITU
SS
IN
OR
AL
NO
Q6
IE
YE
AN
TIB
IOT
IC-C
OR
TIC
OID
GE
NT
AM
ICIN
-PR
ED
NIS
OLO
NE
PR
ED
-GO
PH
TH
ALM
ICN
O
LOT
EP
RE
DN
OL
ET
AB
ON
AT
E-T
OB
RA
MY
CIN
Z
YLE
TO
PH
TH
ALM
ICN
O
NE
OM
YC
IN-B
AC
ITR
AC
IN-P
OLY
-HC
NE
OM
YC
IN
OP
HT
HA
LMIC
NO
NE
OM
YC
IN-P
OLY
MY
XIN
-DE
XA
ME
TH
NE
O-D
EC
AD
RO
NO
PH
TH
ALM
ICN
O
NE
OM
YC
IN-P
OLY
MY
XIN
-HC
PO
LYM
YC
INO
PH
TH
ALM
ICN
O
TO
BR
AM
YC
IN-D
EX
AM
ET
HA
SO
NE
T
OB
RA
DE
XO
PH
TH
ALM
ICN
O
Q6
WE
YE
AN
TIB
IOT
ICS
AZ
ITH
RO
MY
CIN
AZ
AS
ITE
OP
HT
HA
LMIC
NO
BA
CIT
RA
CIN
BA
CIT
RA
CIN
OP
HT
HA
LMIC
NO
BA
CIT
RA
CIN
-PO
LYM
YX
INB
AC
ITR
AC
IN-P
OLY
MY
XIN
OP
HT
HA
LMIC
NO
BA
CIT
RA
CIN
-PO
LYM
YX
IN B
AK
-PO
LY-B
AC
OP
HT
HA
LMIC
NO
BE
SIF
LOX
AC
IN H
CL
BE
SIV
AN
CE
OP
HT
HA
LMIC
NO
CIP
RO
FLO
XA
CIN
HC
LC
ILO
XA
NO
PH
TH
ALM
ICN
O
ER
YT
HR
OM
YC
INE
RY
TH
RO
MY
CIN
OP
HT
HA
LMIC
NO
GA
TIF
LOX
AC
IN
ZY
MA
RO
PH
TH
ALM
ICN
O
GE
NT
AM
ICIN
SU
LFA
TE
GE
NT
AK
OP
HT
HA
LMIC
NO
LEV
OF
LOX
AC
INIQ
UIX
OP
HT
HA
LMIC
NO
MO
XIF
LOX
AC
IN H
CL
VIG
AM
OX
OP
HT
HA
LMIC
NO
NA
TA
MY
CIN
NA
TA
MY
CIN
OP
HT
H S
US
PO
PH
TH
ALM
ICN
O
NE
OM
YC
IN-B
AC
ITR
AC
IN-P
OLY
MY
XIN
NE
OM
YC
IN-B
AC
ITR
AC
IN-P
OLY
MY
XIN
OP
HT
HA
LMIC
NO
NE
OM
YC
IN-P
OLY
MY
XIN
-GR
AM
ICID
INN
EO
MY
CIN
-PO
LYM
YX
IN-G
RA
MIC
IDIN
OP
HT
HA
LMIC
NO
OF
LOX
AC
INO
CU
FLO
XO
PH
TH
ALM
ICN
O
PO
LYM
YX
IN B
SU
L-T
RIM
ET
HO
PR
IMP
OLY
MY
XIN
B S
UL-
TR
IME
TH
OP
RIM
OP
HT
HA
LMIC
NO
TO
BR
AM
YC
IN S
ULF
AT
ET
OB
RE
XO
PH
TH
ALM
ICN
O
Q6
RE
YE
AN
TIH
IST
AM
INE
S
AZ
ELA
ST
INE
HC
LA
ZE
LAS
TIN
E H
CL
OP
HT
HA
LMIC
NO
AZ
ELA
ST
INE
HC
L O
PT
IVA
RO
PH
TH
ALM
ICN
O
EP
INA
ST
INE
HC
LE
LES
TA
TO
PH
TH
ALM
ICN
O
KE
TO
TIF
EN
FU
MA
RA
TE
ALA
WA
YO
PH
TH
ALM
ICN
O
KE
TO
TIF
EN
FU
MA
RA
TE
EY
E I
TC
H R
ELI
EF
OP
HT
HA
LMIC
NO
KE
TO
TIF
EN
FU
MA
RA
TE
ZA
DIT
OR
OP
HT
HA
LMIC
NO
OLO
PA
TA
DIN
E H
CL
PA
TA
NO
LO
PH
TH
ALM
ICN
O
Q6
PE
YE
AN
TII
NF
LAM
MA
TO
RY
AG
EN
TS
BR
OM
FE
NA
C S
OD
IUM
X
IBR
OM
OP
HT
HA
LMIC
NO
DE
XA
ME
TH
AS
ON
E
MA
XID
EX
OP
HT
HA
LMIC
NO
DE
XA
ME
TH
AS
ON
E S
OD
IUM
PH
OS
PH
AT
ED
EX
AM
ET
HA
SO
NE
SO
DIU
M P
HO
SP
HA
TE
OP
HT
HA
LMIC
NO
DIC
LOF
EN
AC
SO
DIU
MV
OLT
AR
EN
OP
HT
HA
LMIC
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
18
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
EY
E A
NT
IIN
FLA
MM
AT
OR
Y A
GE
NT
S (
CO
NT
)D
IFLU
PR
ED
NA
TE
DU
RE
ZO
LO
PH
TH
ALM
ICN
O
FLU
OR
OM
ET
HO
LON
EF
LUO
RO
ME
TH
OLO
NE
OP
HT
HA
LMIC
NO
FLU
OR
OM
ET
HO
LON
E
FM
L F
OR
TE
OP
HT
HA
LMIC
NO
FLU
OR
OM
ET
HO
LON
E A
CE
TA
TE
FLA
RE
XO
PH
TH
ALM
ICN
O
FLU
RB
IPR
OF
EN
SO
DIU
MF
LUR
BIP
RO
FE
N S
OD
IUM
OP
HT
HA
LMIC
NO
KE
TO
RO
LAC
TR
OM
ET
HA
MIN
EK
ET
OR
OLA
C T
RO
ME
TH
AM
INE
OP
HT
HA
LMIC
NO
KE
TO
RO
LAC
TR
OM
ET
HA
MIN
E
AC
ULA
RO
PH
TH
ALM
ICN
O
LOT
EP
RE
DN
OL
ET
AB
ON
AT
ELO
TE
MA
XO
PH
TH
ALM
ICN
O
LOT
EP
RE
DN
OL
ET
AB
ON
AT
E
ALR
EX
OP
HT
HA
LMIC
NO
NE
PA
FE
NA
CN
EV
AN
AC
OP
HT
HA
LMIC
NO
PR
ED
NIS
OLO
NE
AC
ET
AT
EO
MN
IPR
ED
OP
HT
HA
LMIC
NO
PR
ED
NIS
OLO
NE
SO
DIU
M P
HO
SP
HA
TE
PR
ED
NIS
OLO
NE
SO
DIU
M P
HO
SP
HA
TE
OP
HT
HA
LMIC
NO
RIM
EX
OLO
NE
VE
XO
LO
PH
TH
ALM
ICN
O
Q6
VE
YE
AN
TIV
IRA
LS
TR
IFLU
RID
INE
VIR
OP
TIC
OP
HT
HA
LMIC
NO
Q6
EE
YE
IR
RIG
AT
ION
S
OP
HT
HA
LMIC
IR
RIG
AT
ION
SO
LUT
ION
BS
SIN
TR
AO
CU
LRN
O
Q6
YE
YE
PR
EP
AR
AT
ION
S,
MIS
C O
TC
AR
TIF
ICIA
L T
EA
RS
LAC
RI-
LUB
E S
.O.P
.O
PH
TH
ALM
ICN
O
PO
LYV
INY
L A
LCO
HO
LA
KW
A T
EA
RS
OP
HT
HA
LMIC
NO
PR
OP
YLE
NE
GLY
CO
L-G
LYC
ER
IN
SO
OT
HE
OP
HT
HA
LMIC
NO
TY
LOX
AP
OL
EN
UC
LEN
EO
PH
TH
ALM
ICN
O
WH
ITE
PE
TR
OLA
TU
M-M
INE
RA
L O
ILP
UR
ALU
BE
OP
HT
HA
LMIC
NO
Q6
AE
YE
PR
EP
S,
MIS
C (
RX
ON
LY)
SO
DIU
M C
HLO
RID
ES
OD
IUM
CH
LOR
IDE
OP
HT
HA
LMIC
NO
Q6
SE
YE
SU
LFO
NA
MID
S
SU
LFA
CE
TA
MID
E S
OD
IUM
BLE
PH
-10
OP
HT
HA
LMIC
NO
SU
LFA
CE
TA
MID
E S
OD
IUM
-PR
ED
NIS
OLO
NE
BLE
PH
AM
IDE
OP
HT
HA
LMIC
NO
SU
LFA
CE
TA
MID
E-P
RE
DN
ISO
LON
ES
ULF
AC
ET
AM
IDE
-PR
ED
NIS
OLO
NE
OP
HT
HA
LMIC
NO
Q6
CE
YE
VA
SO
CO
NS
TR
ICT
RS
(RX
ON
LY)
NA
PH
AZ
OLI
NE
HC
LA
K-C
ON
OP
HT
HA
LMIC
NO
Q6
DE
YE
VA
SO
CO
NS
TR
ITR
S (
OT
C O
NLY
NA
PH
AZ
OLI
NE
W/
PH
EN
IRA
MIN
EN
AP
HC
ON
-AO
PH
TH
ALM
ICN
O
H0
GF
IBR
OM
YA
LGIA
AG
EN
TS
, S
NR
I
MIL
NA
CIP
RA
N H
CL
SA
VE
LLA
OR
AL
NO
D2
AF
LUO
RID
E P
RE
PA
RA
TIO
NS
SO
DIU
M F
LUO
RID
E
DE
NT
A 5
00
0 P
LUS
DE
NT
AL
YE
S
C6
MF
OLI
C A
CID
PR
EP
AR
AT
ION
S
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
FO
LIC
AC
ID
FO
LIC
AC
IDO
RA
LY
ES
L-M
ET
HY
LFO
LAT
E
DE
PLI
NO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
19
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
B5
RF
ST
GE
N A
NT
IHIS
TA
MIN
E A
NA
LGE
S
AP
AP
-MG
SA
LIC
YLA
TE
-PH
EN
YLT
OLO
X-
CA
FF
EIN
E-A
PA
P-M
AG
DU
RA
BA
C F
OR
TE
OR
AL
NO
D4
GG
AS
TR
IC E
NZ
YM
ES
LAC
TA
SE
D
AIR
Y R
ELI
EF
OR
AL
NO
A1
DG
EN
ER
AL
BR
ON
CH
OD
IALA
TO
RS
IPR
AT
RO
PIU
M B
RO
MID
E H
FA
AT
RO
VE
NT
HF
AIn
ha
lati
on
NO
TIO
TR
OP
IUM
BR
OM
IDE
IN
HS
PIR
IVA
Inh
ala
tio
nN
O
B0
AG
EN
ER
AL
INH
ALA
TIO
N A
GE
NT
S
SO
DIU
M C
HLO
RID
E A
ER
O S
OLN
B
RO
NC
HO
SA
LIN
EIN
HA
LAT
ION
NO
T0
C
SIN
EC
AT
EC
HIN
SV
ER
EG
EN
TO
PIC
AL
NO
C6
GG
ER
IAT
RIC
VIT
AM
IN P
RE
PA
RE
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
MU
LTIP
LE V
ITA
MIN
S W
/ M
INE
RA
LSC
EN
TR
UM
SIL
VE
RO
RA
LY
ES
P5
AG
LUC
OR
TIC
OID
S,
SY
ST
EM
IC
P5
B
BE
CLO
ME
TH
AS
ON
E D
IPR
OP
ION
AT
EQ
VA
RIN
HA
LAT
ION
NO
BU
DE
SO
NID
EP
ULM
ICO
RT
INH
ALA
TIO
NN
O
CO
RT
ISO
NE
AC
ET
AT
E
CO
RT
ISO
NE
OR
AL
NO
DE
XA
ME
TH
AS
ON
ED
EC
AD
RO
NO
RA
LN
O
HY
DR
OC
OR
TIS
ON
E
CO
RT
EF
OR
AL
NO
ME
TH
YLP
RE
DN
ISO
LON
E
ME
DR
OL
OR
AL
NO
PR
ED
NIS
OLO
NE
M
ILLI
PR
ED
OR
AL
NO
PR
ED
NIS
OLO
NE
SO
DIU
M P
HO
SP
HA
TE
PR
ED
NIS
OLO
NE
SO
DIU
M P
HO
SP
HA
TE
OR
AL
NO
PR
ED
NIS
ON
EP
RE
DN
ISO
NE
OR
AL
NO
P5
CG
LUC
OR
TIC
OID
S,
TO
PIC
AL
FLU
NIS
OLI
DE
AE
RO
BID
INH
ALA
TIO
NN
O
FLU
TIC
AS
ON
E P
RO
PIO
NA
TE
FLO
VE
NT
DIS
KU
SIN
HA
LAT
ION
NO
MO
ME
TA
SO
NE
FU
RO
AT
EA
SM
AN
EX
INH
ALA
TIO
NN
O
TR
IAM
CIN
OLO
NE
AC
ET
ON
IDE
AZ
MA
CO
RT
INH
ALA
TIO
NN
O
S2
CG
OLD
SA
LTS
AU
RA
NO
FIN
RID
AU
RA
OR
AL
YE
S
P1
AG
RO
WT
H H
OR
MO
NE
S
SO
MA
TR
OP
INH
UM
AT
RO
PE
INJE
CT
ION
NO
N1
BH
EM
AT
INIC
S,
OT
HE
R
DA
RB
EP
OE
TIN
ALF
A-P
OLY
SO
RB
AT
E 8
0
DA
RB
EP
OE
TIN
ALF
A-P
OLY
SO
RB
AT
E 8
0
SO
LNIN
JEC
TIO
NY
ES
EP
OE
TIN
ALF
A
PR
OC
RIT
INJE
CT
ION
YE
S
M9
SH
EM
OR
RH
EO
LOG
IC A
GE
NT
PE
NT
OX
IFY
LLIN
ET
RE
NT
AL
OR
AL
YE
S
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
20
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
Q3
HH
EM
OR
RH
OID
AL
PR
EP
(C
ON
T)
DIB
UC
AIN
EN
UP
ER
CA
INA
LR
EC
TA
LY
ES
LID
OC
AIN
ELM
X 5
TO
PIC
AL
YE
S
Q3
DH
EM
OR
RH
OID
AL
PR
EP
AR
AT
ION
S
HY
DR
OC
OR
TIS
ON
E -
PR
AM
OX
INE
AN
ALP
RA
M H
CR
EC
TA
LY
ES
PH
EN
YLE
PH
-SH
AR
K L
IVE
R O
IL-C
OC
OA
BU
TT
ER
H
EM
OR
RH
OID
AL
SU
PP
OS
ITO
RIE
SR
EC
TA
LY
ES
PR
AM
OX
INE
HC
LP
RO
CT
OF
OA
MT
OP
ICA
LY
ES
PR
AM
OX
-PE
-GLY
CE
RIN
-PE
TR
OLA
TU
M
RE
CT
AL
PR
EP
AR
AT
ION
HR
EC
TA
LY
ES
Q3
I
LID
OC
AIN
E-H
YD
RO
CO
RT
ISO
NE
LI
DA
ZO
NE
HC
RE
CT
AL
YE
S
M9
KH
EP
AR
IN P
RE
PA
RA
TIO
NS
DA
LTE
PA
RIN
SO
DIU
MF
RA
GM
INS
UB
-QN
O
EN
OX
AP
AR
INLO
VE
NO
XS
UB
-QN
O
FO
ND
AP
AR
INU
X S
OD
IUM
AR
IXT
RA
SU
B-Q
NO
W5
FH
EP
AT
ITIS
B T
RE
AT
ME
NT
LAM
IVU
DIN
EE
PIV
IR H
BV
OR
AL
YE
S
W5
GH
EP
AT
ITIS
C T
RE
AT
ME
NT
PE
GIN
TE
RF
ER
ON
ALF
A-2
AP
EG
AS
YS
SU
B-Q
YE
S
RIB
AV
IRIN
RIB
AS
PH
ER
EO
RA
LY
ES
Z2
DH
IST
AM
INE
H2
IN
HIB
ITO
RS
CIM
ET
IDIN
EC
IME
TID
INE
OR
AL
NO
FA
MO
TID
INE
PE
PC
ID A
CO
RA
LN
O
NIZ
AT
IDIN
EA
XID
OR
AL
NO
RA
NIT
IDIN
E H
CL
ZA
NT
AC
OR
AL
NO
W5
QH
IV-A
NT
IRE
TR
OV
IAL
CO
MB
INA
TIO
N
EF
AV
IRE
NZ
-EM
TR
ICIT
AB
INE
-TE
NO
FO
VIR
A
TR
IPLA
OR
AL
NO
W5
OH
IV-S
PE
C A
V-N
UC
LEO
SID
E/T
IDE
EM
TR
ICIT
AB
INE
-TE
NO
FO
VIR
DIS
OP
RO
XIL
FU
MA
RA
TE
TR
UV
AD
AO
RA
LN
O
W5
JH
IV-S
PE
C N
EC
LEO
SID
E A
NLG
, R
TI
LAM
IVU
DIN
E
EP
IVIR
OR
AL
NO
ZID
OV
UD
INE
ZID
OV
UD
INE
OR
AL
NO
W5
KH
IV-S
PE
C N
ON
-NE
CLE
OS
IDE
, R
TI
EF
AV
IRE
NZ
SU
ST
IVA
OR
AL
NO
W5
LH
IV-S
PE
C N
UC
LEO
SID
E,
RT
I C
OM
BO
LAM
IVU
DIN
E-Z
IDO
VU
DIN
E
CO
MB
IVIR
OR
AL
NO
W5
MH
IV-S
PE
C P
RO
TE
AS
E I
NH
IB C
OM
BO
LOP
INA
VIR
-RIT
ON
AV
IR
KA
LET
RA
OR
AL
NO
M4
MH
MG
CO
A I
NH
IB C
HO
LST
AB
IN
HIB
EZ
ET
IMIB
E-S
IMV
AS
TA
TIN
V
YT
OR
INO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
21
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
M4
DH
MG
CO
A R
ED
UC
TA
SE
IN
HIB
ITO
RS
AT
OR
VA
ST
AT
IN C
ALC
IUM
LIP
ITO
RO
RA
LY
ES
FLU
VA
ST
AT
IN S
OD
IUM
LES
CO
L X
LO
RA
LY
ES
LOV
AS
TA
TIN
ALT
OP
RE
VO
RA
LY
ES
PIT
AV
AS
TA
TIN
CA
LCIU
M
LIV
ALO
OR
AL
YE
S
PR
AV
AS
TA
TIN
SO
DIU
MP
RA
VA
CH
OL
OR
AL
YE
S
RO
SU
VA
ST
AT
IN C
ALC
IUM
C
RE
ST
OR
OR
AL
YE
S
SIM
VA
ST
AT
INZ
OC
OR
OR
AL
YE
S
M4
LH
MG
CO
A R
ED
UC
TS
E I
NH
IB N
IAC
IN
NIA
CIN
-LO
VA
ST
AT
INA
DV
ICO
RO
RA
LY
ES
NIA
CIN
-SIM
VA
ST
AT
IN
SIM
CO
RO
RA
LY
ES
M4
GH
YP
ER
GLY
CE
MIC
S
GLU
CA
GO
N (
RD
NA
)G
LUC
AG
ON
EM
ER
GE
NC
Y K
ITIN
JEC
TIO
NY
ES
GLU
CO
SE
INS
TA
-GLU
CO
SE
OR
AL
YE
S
P4
DH
YP
ER
PA
RA
TH
YR
OID
TX
AG
EN
TS
DO
XE
RC
ALC
IFE
RO
LH
EC
TO
RO
LO
RA
LY
ES
PA
RIC
ALC
ITO
LZ
EM
PLA
RO
RA
LY
ES
H8
BH
YP
NO
TIC
S-M
ELA
TO
NIN
AG
ON
IST
S
RA
ME
LTE
ON
R
OZ
ER
EM
OR
AL
NO
H8
FH
YP
NO
TIC
S-M
ELA
TO
NIN
CO
MB
OS
ME
LAT
ON
INM
ELA
TO
NIN
OR
AL
NO
C4
SH
YP
OG
LY I
NS
UL
RE
L B
IGU
AN
CM
B
GLY
BU
RID
E-M
ET
FO
RM
IN
GLU
CO
VA
NC
EO
RA
LY
ES
C4
TH
YP
OG
LY I
NS
UL
RE
SP
BIG
UA
N C
MB
RO
SIG
LIT
AZ
ON
E M
ALE
AT
E-M
ET
FO
RM
IN H
CL
AV
AN
DA
ME
TO
RA
LY
ES
C4
LH
YP
OG
LYC
EM
IC N
ON
-SU
LFO
NY
LU
ME
TF
OR
MIN
HC
L M
ET
FO
RM
IN H
CL
OR
AL
YE
S
C4
KH
YP
OG
LYC
EM
IC S
ULF
ON
YLU
RE
AS
GLI
ME
PIR
IDE
AM
AR
YL
OR
AL
YE
S
GLI
PIZ
IDE
G
LIP
IZID
EO
RA
LY
ES
GLY
BU
RID
EG
LYB
UR
IDE
OR
AL
YE
S
NA
TE
GLI
NID
ES
TA
RLI
XO
RA
LY
ES
C4
MH
YP
OG
LYC
EM
ICS
ALP
HA
IN
HIB
AC
AR
BO
SE
P
RE
CO
SE
OR
AL
YE
S
C4
NH
YP
OG
LYC
EM
ICS
IN
SU
LIN
EN
H
PIO
GLI
TA
ZO
NE
HC
L A
CT
OS
OR
AL
YE
S
PIO
GLI
TA
ZO
NE
HC
L-M
ET
FO
RM
INA
CT
OP
LUS
ME
TO
RA
LY
ES
RO
SIG
LIT
AZ
ON
E M
ALE
AT
E
AV
AN
DIA
OR
AL
YE
S
A4
FH
YP
OT
EN
SIV
ES
AN
GIO
RE
CP
T A
NT
CA
ND
ES
AR
TA
N C
ILE
XE
TIL
A
TA
CA
ND
OR
AL
YE
S
EP
RO
SA
RT
AN
ME
SY
LAT
ET
EV
ET
EN
OR
AL
YE
S
IRB
ES
AR
TA
NA
VA
PR
OO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
22
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
HY
PO
TE
NS
IVE
S A
NG
IO R
EC
PT
AN
T (
CO
NT
)LO
SA
RT
AN
PO
TA
SS
IUM
C
OZ
AA
RO
RA
LY
ES
OLM
ES
AR
TA
N M
ED
OX
OM
ILB
EN
ICA
RO
RA
LY
ES
TE
LMIS
AR
TA
N
MIC
AR
DIS
OR
AL
YE
S
VA
LSA
RT
AN
D
IOV
AN
OR
AL
YE
S
A4
DH
YP
OT
EN
SIV
ES
AN
GIO
TE
NS
IN B
LK
BE
NA
ZE
PR
IL H
CL
BE
NA
ZE
PR
IL H
CL
OR
AL
YE
S
CA
PT
OP
RIL
CA
PT
OP
RIL
OR
AL
YE
S
EN
ALA
PR
IL M
ALE
AT
EE
NA
LAP
RIL
MA
LEA
TE
OR
AL
YE
S
FO
SIN
OP
RIL
SO
DIU
MF
OS
INO
PR
IL S
OD
IUM
OR
AL
YE
S
LIS
INO
PR
ILP
RIN
IVIL
OR
AL
YE
S
MO
EX
IPR
IL H
CL
UN
IVA
SC
OR
AL
YE
S
PE
RIN
DO
PR
IL E
RB
UM
INE
AC
EO
NO
RA
LY
ES
QU
INA
PR
IL H
CL
QU
INA
PR
IL H
CL
OR
AL
YE
S
RA
MIP
RIL
ALT
AC
EO
RA
LY
ES
TR
AN
DO
LAP
RIL
MA
VIK
OR
AL
YE
S
A4
BH
YP
OT
EN
SIV
ES
SY
MP
AT
HO
LYT
IC
CLO
NID
INE
HC
LC
AT
AP
RE
SO
RA
LY
ES
CLO
NID
INE
HC
L T
D P
AT
CH
CLO
NID
INE
TR
AN
SD
ER
MY
ES
GU
AN
FA
CIN
E H
CL
TE
NE
XO
RA
LY
ES
A4
AH
YP
OT
EN
SIV
ES
VA
SO
DIL
AT
OR
S
HY
DR
ALA
ZIN
E H
CL
AP
RE
SO
LIN
EO
RA
LY
ES
MIN
OX
IDIL
MIN
OX
IDIL
OR
AL
YE
S
Z2
LIM
MU
NO
GLO
BU
LIN
E(I
GE
) B
LOC
KE
RS
OM
ALI
ZU
MA
BX
OLA
IRS
UB
-QY
ES
Z2
GIM
MU
NO
MO
DU
LAT
OR
S
IMIQ
UIM
OD
A
LDA
RA
TO
PIC
AL
YE
S
INT
ER
FE
RO
N G
AM
MA
-1B
AC
TIM
MU
NE
SU
B-Q
YE
S
Z2
EIM
MU
NO
SU
PP
RE
SIV
ES
AZ
AT
HIO
PR
INE
AZ
AT
HIO
PR
INE
OR
AL
YE
S
CY
CLO
SP
OR
INE
G
EN
GR
AF
OR
AL
YE
S
MY
CO
PH
EN
OLA
TE
MO
FE
TIL
CE
LLC
EP
TO
RA
LY
ES
MY
CO
PH
EN
OLA
TE
SO
DIU
MM
YF
OR
TIC
OR
AL
YE
S
SIR
OLI
MU
S
RA
PA
MU
NE
OR
AL
YE
S
TA
CR
OLI
MU
SP
RO
GR
AF
OR
AL
YE
S
TA
CR
OLI
MU
ST
AC
RO
LIM
US
AN
HY
DR
OU
SO
RA
LY
ES
W5
CIN
HIB
ITO
RS
HIV
PR
OT
EA
SE
AT
AZ
AN
AV
IR S
ULF
AT
ER
EY
AT
AZ
OR
AL
NO
IND
INA
VIR
SU
LFA
TE
CR
IXIV
AN
OR
AL
NO
NE
LFIN
AV
IR M
ES
YLA
TE
VIR
AC
EP
TO
RA
LN
O
RIT
ON
AV
IRN
OR
VIR
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
23
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
C4
RIN
SU
LIN
RE
SP
ON
RE
LEA
SE
CO
MB
PIO
GLI
TA
ZO
NE
HC
L-G
LIM
EP
IRID
ED
UE
TA
CT
OR
AL
YE
S
RO
SIG
LIT
AZ
ON
E M
ALE
AT
E-G
LIM
EP
IRID
EA
VA
ND
AR
YL
OR
AL
YE
S
C4
GIN
SU
LIN
S
INS
ULI
N
INS
ULI
NS
CY
ES
All
str
en
gth
s a
nd
fo
rmu
lati
on
s o
f in
ject
ab
le i
nsu
lin
are
co
ve
red
fo
r a
pp
rop
ria
te
con
dit
ion
s a
llo
we
d i
n t
he
cla
im
J9A
INT
ES
TIN
AL
MO
TIL
ITY
ST
IMU
LAN
ME
TO
CLO
PR
AM
IDE
HC
L R
EG
LAN
OR
AL
NO
C3
HIO
DIN
E R
EP
LAC
EM
EN
T
PO
TA
SS
IUM
IO
DID
ES
SK
IO
RA
LY
ES
C3
BIR
ON
RE
PLA
CE
ME
NT
All
iro
n s
alt
s a
nd
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d c
on
dit
ion
s
FE
FU
MA
RA
TE
W/
B1
2-V
IT C
-FA
-IF
CF
ER
OC
ON
OR
AL
YE
S
FE
RR
OU
S G
LUC
ON
AT
EF
ER
GO
NO
RA
LY
ES
FE
RR
OU
S S
ULF
AT
EF
EO
SO
LO
RA
LY
ES
PO
LYS
AC
CH
AR
IDE
IR
ON
CO
MP
LEX
F
ER
RE
X 1
50
OR
AL
YE
S
L6A
IRR
ITA
NT
S
ALO
E V
ER
AA
LOE
VE
RA
TO
PIC
AL
NO
CA
MP
HO
R &
ME
NT
HO
LS
AR
NA
TO
PIC
AL
NO
CA
MP
HO
R &
ME
NT
HO
L F
RE
EZ
E I
TT
OP
ICA
LN
O
CA
MP
HO
R-E
UC
ALY
PT
US
-ME
NT
HO
L V
ICK
S V
AP
OR
UB
TO
PIC
AL
NO
CA
PS
AIC
IN
AR
TH
RIT
IS P
AIN
RE
LIE
FT
OP
ICA
LN
O
CA
PS
AIC
IN I
N L
IDO
CA
INE
VE
HIC
LE
ZO
ST
RIX
TO
PIC
AL
NO
CA
PS
AIC
IN-M
EN
TH
OL-
ME
TH
YL
SA
LIC
YLA
TE
ZIK
ST
OP
ICA
LN
O
CA
PS
ICU
M O
LEO
RE
SIN
C
AP
SIC
UM
OLE
OR
ES
INT
OP
ICA
LN
O
CA
PS
ICU
M O
LEO
RE
SIN
T
RIX
AIC
INT
OP
ICA
LN
O
LIN
IME
NT
S &
RU
BS
BIO
FLE
XO
RT
OP
ICA
LN
O
LIN
IME
NT
S &
RU
BS
B
AN
ALG
TO
PIC
AL
NO
LIN
IME
NT
S &
RU
BS
S
ALO
NP
AS
TO
PIC
AL
NO
ME
NT
HO
LB
EN
GA
YT
OP
ICA
LN
O
ME
NT
HO
L P
AIN
RE
LIE
VIN
G P
AT
CH
TO
PIC
AL
NO
ME
NT
HO
L-M
ET
HY
L S
ALI
CY
LAT
E
TH
ER
A-G
ES
ICT
OP
ICA
LN
O
ME
TH
YL
SA
LIC
YLA
TE
ME
TH
YL
SA
LIC
YLA
TE
TO
PIC
AL
NO
TR
OLA
MIN
E S
ALI
CY
LAT
EM
OB
ISY
LT
OP
ICA
LN
O
TR
OLA
MIN
E S
ALI
CY
LAT
E
AN
ALG
ES
IC C
RE
ME
TO
PIC
AL
NO
TR
OLA
MIN
E S
ALI
CY
LAT
E
AS
PE
RC
RE
ME
TO
PIC
AL
NO
W9
AK
EK
YT
OLI
DE
S
TE
LIT
HR
OM
YC
IN
KE
TE
KO
RA
LN
O
L5O
KE
RA
T-G
LUC
OC
OR
T C
OM
B
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
24
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
L5A
KE
RA
TO
LYT
ICS
SIL
VE
R N
ITR
AT
E
SIL
VE
R N
ITR
AT
E A
PP
LIC
AT
OR
TO
PIC
AL
NO
UR
EA
UR
EA
TO
PIC
AL
NO
UR
EA
-HY
ALU
RO
NA
TE
SO
DIU
M
UR
EA
-HY
ALU
RO
NA
TE
SO
DIU
M S
US
PT
OP
ICA
LN
O
Q3
SLA
XA
TIV
E L
OC
AL/
RE
CT
AL
BIS
AC
OD
YL
DU
LCO
LAX
RE
CT
AL
NO
DO
CU
SA
TE
SO
DIU
MC
OLA
CE
RE
CT
AL
NO
GLY
CE
RIN
S
AN
I-S
UP
PR
EC
TA
LN
O
MIN
ER
AL
OIL
MIN
ER
AL
OIL
EN
EM
AR
EC
TA
LN
O
SO
DIU
M P
HO
SP
HA
TE
SP
HO
SP
HA
TE
EN
EM
AR
EC
TA
LN
O
D6
SLA
XA
TIV
ES
AN
D C
AT
HA
RT
ICS
All
la
xati
ve
s a
nd
bo
we
l p
rep
pro
du
cts
are
co
ve
red
fo
r a
llo
we
d c
on
dit
ion
s
D6
TLA
XA
TIV
ES
AN
D C
AT
HA
RT
ICS
BIS
AC
OD
YL
DU
LCO
LAX
OR
AL
YE
SB
ISA
CO
DY
L T
AB
& P
EG
33
50
-KC
L-S
OD
BIC
AR
B-N
AC
LH
ALF
LYT
ELY
OR
AL
YE
S
BIS
MU
TH
SU
BS
ALI
CY
LAT
EK
AO
PE
CT
AT
EO
RA
LY
ES
CA
LCIU
M P
OLY
CA
RB
OP
HIL
F
IBE
R T
AB
SO
RA
LY
ES
CA
SA
NT
HR
AN
OL-
DS
SD
OC
US
AT
E S
OD
IUM
CA
SA
NT
HR
AN
OL
OR
AL
YE
S
CE
LLU
LOS
EU
NIF
IBE
RO
RA
LY
ES
DO
CU
SA
TE
CA
LCIU
M
SU
R-Q
-LA
XO
RA
LY
ES
DO
CU
SA
TE
SO
DIU
M
CO
LAC
EO
RA
LY
ES
LAC
TU
LOS
E
CO
NS
TU
LOS
EO
RA
LY
ES
LUB
IPR
OS
TO
NE
AM
ITIZ
AO
RA
LY
ES
MA
GN
ES
IUM
CIT
RA
TE
MA
GN
ES
IUM
CIT
RA
TE
OR
AL
YE
S
MA
GN
ES
IUM
CIT
RA
TE
C
ITR
OM
AO
RA
LY
ES
MA
GN
ES
IUM
SU
LFA
TE
E
PS
OM
SA
LTO
RA
LY
ES
ME
TH
YLC
ELL
ULO
SE
CIT
RU
CE
LO
RA
LY
ES
MIL
K O
F M
AG
NE
SIA
MIL
K O
F M
AG
NE
SIA
OR
AL
YE
S
MIN
ER
AL
OIL
KO
ND
RE
MU
LO
RA
LY
ES
MIN
ER
AL
OIL
MIN
ER
AL
OIL
OR
AL
YE
S
PE
G 3
35
0-K
CL-
NA
BIC
AR
B-N
AC
L-N
A S
ULF
AT
EG
OLY
TE
LYO
RA
LY
ES
PE
G 3
35
0-K
CL-
SO
D B
ICA
RB
-NA
CL
NU
LYT
ELY
OR
AL
YE
S
PO
LYE
TH
YLE
NE
GLY
CO
L 3
35
0
GLY
CO
LAX
OR
AL
YE
S
PO
LYE
TH
YLE
NE
GLY
CO
L 3
35
0
MIR
ALA
XO
RA
LY
ES
PS
YLL
IUM
KO
NS
YL
OR
AL
YE
S
SE
NN
OS
IDE
SS
EN
OK
OT
OR
AL
YE
S
SE
NN
OS
IDE
S-D
OC
US
AT
E S
OD
IUM
SE
NN
A S
OR
AL
YE
S
SE
NN
OS
IDE
S-D
OC
US
AT
E S
OD
IUM
P
ER
I-C
OLA
CE
OR
AL
YE
S
SO
D P
HO
S M
ON
O-S
OD
PH
OS
DI
VIS
ICO
LO
RA
LY
ES
SO
DIU
M P
HO
SP
HA
TE
SP
HO
SP
HO
-SO
DA
OR
AL
YE
S
WH
EA
T D
EX
TR
IN
BE
NE
FIB
ER
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
25
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
N1
CLE
UK
OC
YT
E (
WB
C)
ST
IMU
LAN
TS
FIL
GR
AS
TIM
NE
UP
OG
EN
INJE
CT
ION
NO
PE
GF
ILG
RA
ST
IM
NE
ULA
ST
AS
UB
-QN
O
Z4
BLE
UK
OT
RIE
NE
RE
CE
PT
OR
AN
TA
G
MO
NT
ELU
KA
ST
SO
DIU
M
SIN
GU
LAIR
OR
AL
YE
S
ZA
FIR
LUK
AS
T
AC
CO
LAT
EO
RA
LY
ES
W1
KLI
NC
OS
AM
IDE
S
CLI
ND
AM
YC
IN H
CL
CLI
ND
AM
YC
IN H
CL
OR
AL
NO
CLI
ND
AM
YC
IN P
ALM
ITA
TE
CLE
OC
IN P
ALM
ITA
TE
OR
AL
NO
M4
ILI
PO
TR
OP
IC/C
A C
HA
N B
LOC
K C
OM
BO
AM
LOD
IPIN
E B
ES
YLA
TE
-AT
OR
VA
ST
AT
IN
CA
LCIU
MC
AD
UE
TO
RA
LY
ES
M4
ELI
PO
TR
OP
ICS
FE
NO
FIB
RA
TE
TR
ICO
RO
RA
LY
ES
FE
NO
FIB
RA
TE
A
NT
AR
AO
RA
LY
ES
FIS
H O
ILF
ISH
OIL
OR
AL
YE
S
GE
MF
IBR
OZ
ILG
EM
FIB
RO
ZIL
OR
AL
YE
S
LEC
ITH
INLE
CIT
HIN
OR
AL
YE
S
NIA
CIN
NIA
SP
AN
OR
AL
YE
S
OM
EG
A-3
FA
TT
Y A
CID
SO
ME
GA
-3O
RA
LY
ES
OM
EG
A-3
-AC
ID E
TH
YL
ES
TE
RS
LOV
AZ
AO
RA
LY
ES
VIT
AM
INS
W/
LIP
OT
RO
PIC
SLI
PO
TR
IAD
OR
AL
YE
S
M4
CLI
PO
TR
OP
ICS
(C
ON
T 2
)
CH
OLI
NE
FE
NO
FIB
RA
TE
TR
ILIP
IXO
RA
LN
O
M4
FLI
PO
TR
OP
ICS
(C
ON
T)
EZ
ET
IMIB
EZ
ET
IAO
RA
LY
ES
H0
ALO
CA
L A
NE
ST
HE
TIC
S
BE
NZ
OC
AIN
E D
EN
TA
L P
AS
TE
OR
AB
AS
E-B
MU
CO
US
ME
MN
O
LID
OC
AIN
E H
CL
LID
OC
AIN
E H
CL
LOC
AM
UC
OU
S M
EM
NO
PH
EN
OL
CH
LOR
AS
EP
TIC
MU
CO
US
ME
MN
O
H0
BLO
CA
L A
NE
ST
HE
TIC
S (
CO
NT
)
BE
NZ
OC
AIN
E D
EN
TA
L G
EL
AN
BE
SO
LM
UC
OU
S M
EM
NO
BE
NZ
OC
AIN
E D
EN
TA
L G
EL
HU
RR
ICA
INE
MU
CO
US
ME
MN
O
BE
NZ
OC
AIN
E-M
EN
TH
OL
CE
PA
CO
L S
OR
E T
HR
OA
TM
UC
OU
S M
EM
NO
CE
TY
LPY
RID
INIU
M C
HLO
RID
E
CE
PA
CO
LM
UC
OU
S M
EM
NO
LID
OC
AIN
E H
CL
XY
LOC
AIN
EM
UC
OU
S M
EM
NO
LID
OC
AIN
E H
CL
VIS
CO
US
LID
OC
AIN
E H
CL
VIS
CO
US
MU
CO
US
ME
MN
O
R1
MLO
OP
DIU
RE
TIC
S
BU
ME
TA
NID
EB
UM
ET
AN
IDE
OR
AL
YE
S
FU
RO
SE
MID
ELA
SIX
OR
AL
YE
S
TO
RS
EM
IDE
D
EM
AD
EX
OR
AL
YE
S
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
26
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
W1
DM
AC
RO
LID
ES
AZ
ITH
RO
MY
CIN
AZ
ITH
RO
MY
CIN
OR
AL
NO
AZ
ITH
RO
MY
CIN
ZIT
HR
OM
AX
OR
AL
NO
CLA
RIT
HR
OM
YC
IN
BIA
XIN
OR
AL
NO
ER
YT
HR
OC
IN S
TE
AR
AT
EE
RY
TH
RO
CIN
ST
EA
RA
TE
OR
AL
NO
ER
YT
HR
OM
YC
INE
RY
-TA
BO
RA
LN
O
ER
YT
HR
OM
YC
IN E
TH
YLS
UC
CIN
AT
EE
RY
TH
RO
MY
CIN
ET
HY
LSU
CC
INA
TE
OR
AL
NO
C1
HM
AG
NE
SIU
M R
EP
LAC
EM
EN
TA
ll m
ag
ne
siu
m s
alt
s a
nd
ora
l d
osa
ge
fo
rms
ae
co
ve
ed
fo
r a
llo
we
d c
on
dit
ion
s
MA
GN
ES
IUM
CH
LOR
IDE
MA
G6
4O
RA
LY
ES
MA
GN
ES
IUM
GLU
CO
NA
TE
MA
G-G
OR
AL
YE
S
MA
GN
ES
IUM
LA
CT
AT
EM
AG
-TA
B S
RO
RA
LY
ES
MA
GN
ES
IUM
OX
IDE
MA
GO
XO
RA
LY
ES
H7
JM
AO
IS-N
ON
-SE
LEC
T &
IR
RE
VE
RS
IBL
PH
EN
ELZ
INE
SU
LFA
TE
N
AR
DIL
OR
AL
NO
TR
AN
YLC
YP
RO
MIN
E S
ULF
AT
ET
RA
NY
LCY
PR
OM
INE
SU
LFA
TE
OR
AL
NO
X2
AM
ED
SU
PP
LIE
S N
EE
DLE
S
Insu
lin
Sy
rin
ge
& N
ee
dle
ULT
ICA
RE
MIS
CE
LLN
O
C8
AM
ET
ALL
IC P
OIS
ON
AN
TID
OT
ES
SU
CC
IME
RC
HE
ME
TO
RA
LN
O
P5
SM
INE
RA
LOC
OR
TIC
OID
S
FLU
DR
OC
OR
TIS
ON
E A
CE
TA
TE
FLU
DR
OC
OR
TIS
ON
E A
CE
TA
TE
OR
AL
NO
Q6
GM
IOT
ICS
AN
D O
TH
ER
IN
TR
AO
CU
LA
AP
RA
CLO
NID
INE
HC
LIO
PID
INE
OP
HT
HA
LMIC
NO
BE
TA
XO
LOL
HC
LB
ET
OP
TIC
SO
PH
TH
ALM
ICN
O
BIM
AT
OP
RO
ST
LUM
IGA
NO
PH
TH
ALM
ICN
O
BR
IMO
NID
INE
TA
RT
RA
TE
A
LPH
AG
AN
PO
PH
TH
ALM
ICN
OB
RIM
ON
IDIN
E T
AR
TR
AT
E-T
IMO
LOL
MA
LEA
TE
CO
MB
IGA
NO
PH
TH
ALM
ICN
O
BR
INZ
OLA
MID
EA
ZO
PT
OP
HT
HA
LMIC
NO
CA
RB
AC
HO
LIS
OP
TO
CA
RB
AC
HO
LO
PH
TH
ALM
ICN
O
CA
RT
EO
LOL
HC
LC
AR
TE
OLO
L H
CL
OP
HT
HA
LMIC
NO
DO
RZ
OLA
MID
E
TR
US
OP
TO
PH
TH
ALM
ICN
O
DO
RZ
OLA
MID
E H
CL-
TIM
OLO
L M
ALE
AT
E
CO
SO
PT
OP
HT
HA
LMIC
NO
IMO
LOL
MA
LEA
TE
IST
ALO
LO
PH
TH
ALM
ICN
O
LAT
AN
OP
RO
ST
XA
LAT
AN
OP
HT
HA
LMIC
NO
LEV
OB
UN
OLO
L H
CL
BE
TA
GA
NO
PH
TH
ALM
ICN
O
PIL
OC
AR
PIN
E H
CL
ISO
PT
O C
AR
PIN
EO
PH
TH
ALM
ICN
O
TIM
OLO
L M
ALE
AT
ET
IMO
PT
ICO
PH
TH
ALM
ICN
O
TR
AV
OP
RO
ST
TR
AV
AT
AN
OP
HT
HA
LMIC
NO
W2
GM
ISC
AN
TIB
AC
TE
RIA
L C
HE
MO
TH
ER
FO
SF
OM
YC
IN T
RO
ME
TH
AM
INE
MO
NU
RO
LO
RA
LN
O
ME
TH
EN
AM
INE
HIP
PU
RA
TE
H
IPR
EX
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
27
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
MIS
C A
NT
IBA
CT
ER
IAL
CH
EM
OT
HE
R (
CO
NT
)M
ET
HE
NA
MIN
E M
AN
DE
LAT
EM
AN
DE
LAM
INE
OR
AL
NO
ME
TH
EN
AM
INE
-HY
OS
C-M
ET
H B
LUE
-BE
NZ
AC
ID-P
HE
NY
L S
AL
PR
OS
ED
-DS
OR
AL
NO
ME
TH
EN
AM
INE
-HY
OS
-ME
TH
BLU
E-S
OD
PH
OS
-PH
EN
SA
LD
AR
CA
LMA
OR
AL
NO
TR
IME
TH
OP
RIM
PR
IMS
OL
OR
AL
NO
C3
MM
ISC
ELL
AN
EO
US
MIN
ER
AL
RE
PL
MU
LTIP
LE M
INE
RA
LS W
/ F
E-F
A-B
12
-VIT
C-
DS
SG
LUT
OF
AC
-MX
OR
AL
NO
L9A
MIS
CE
LLA
NE
OU
S T
OP
ICA
L A
GE
NT
S
EM
OLL
IEN
TC
ER
AV
ET
OP
ICA
LN
O
SO
AP
& C
LEA
NS
ER
SP
ER
I-W
AS
HT
OP
ICA
LN
O
UR
EA
CR
EA
MA
QU
A C
AR
ET
OP
ICA
LN
O
H2
HM
ON
OA
MIN
EO
XID
AS
E (
MA
O)
INH
IB
SE
LEG
ILIN
E T
D
EM
SA
MT
RA
NS
DE
RM
NO
B3
AM
UC
OLY
TIC
S
AC
ET
YLC
YS
TE
INE
AC
ET
YLC
YS
TE
INE
MIS
CE
LLN
O
DO
RN
AS
E A
LFA
IN
HA
L S
OLN
PU
LMO
ZY
ME
INH
ALA
TIO
NN
O
C6
ZM
ULT
IVIT
AM
IN P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
B-C
OM
PLE
X W
/ C
& E
+ Z
N
ST
RE
SS
WIT
H Z
INC
OR
AL
YE
S
MU
LTIP
LE V
ITA
MIN
TA
BM
ULT
I-D
AY
OR
AL
YE
S
MU
LTIP
LE V
ITA
MIN
S W
/ M
INE
RA
LS
CE
NT
RU
MO
RA
LY
ES
Q6
JM
YD
RIA
TIC
S
AT
RO
PIN
E S
ULF
AT
EA
TR
OP
INE
SU
LFA
TE
OP
HT
HA
LMIC
NO
CY
CLO
PE
NT
OLA
TE
HC
LC
YC
LOG
YL
OP
HT
HA
LMIC
NO
CY
CLO
PE
NT
OLA
TE
HC
L A
K-P
EN
TO
LAT
EO
PH
TH
ALM
ICN
O
HO
MA
TR
OP
INE
HB
RH
OM
AT
RO
PA
IRE
OP
HT
HA
LMIC
NO
SC
OP
OLA
MIN
E H
BR
IS
OP
TO
HY
OS
CIN
EO
PH
TH
ALM
ICN
O
B4
CN
AR
C A
NT
ITU
SS
-AN
TIC
HO
LIN
CM
B
HY
DR
OC
OD
ON
E B
T-H
OM
AT
RO
PIN
E M
BR
HY
DR
OC
OD
ON
E B
T-H
OM
AT
RO
PIN
E M
BR
OR
AL
NO
B3
QN
AR
C A
NT
ITU
SS
-AN
TIH
IST
-DE
CO
NG
BR
OM
PH
EN
IRA
MIN
E-H
YD
RO
CO
D-P
SE
BR
OM
PH
EN
IRA
MIN
E-H
YD
RO
CO
D-P
SE
OR
AL
NO
PH
EN
YLE
PH
-CH
LOR
PH
EN
W/
HY
DR
OC
OD
ON
E S
YR
UP
H-C
TU
SS
IVE
OR
AL
NO
PH
EN
YLE
PH
RIN
E-B
RO
MP
HE
NP
OLY
-TU
SS
INO
RA
LN
OP
HE
NY
LEP
HR
INE
-CH
LOR
PH
EN
-
DIH
YD
RO
CO
DE
INE
C
OLD
CO
UG
H P
DO
RA
LN
OP
HE
NY
LEP
HR
INE
-DE
XB
RO
MP
HE
N-
HY
DR
OC
OD
ON
E
CY
TU
SS
-HC
OR
AL
NO
PH
EN
YLE
PH
RIN
E-P
YR
ILA
MIN
E W
/ C
OD
EIN
EP
RO
-RE
D A
CO
RA
LN
O
PH
EN
YLE
PH
RIN
E-P
YR
ILA
MIN
E-D
M
CO
DA
L-D
HO
RA
LN
O
PR
OM
ET
HA
ZIN
E V
C-C
OD
EIN
EP
RO
ME
TH
AZ
INE
VC
-CO
DE
INE
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
28
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
NA
RC
AN
TIT
US
S-A
NT
IHIS
T-D
EC
ON
G (
CO
NT
)
PS
EU
DO
EP
H-B
RO
MP
HE
N W
/
HY
DR
OC
OD
ON
EV
ISV
EX
HC
OR
AL
NO
PS
EU
DO
EP
HE
D-B
RO
MP
HE
NB
RO
MC
OM
P H
CO
RA
LN
O
B4
QN
AR
C A
NT
ITU
SS
-DE
CO
NG
-EX
PE
CT
PS
EU
DO
EP
HE
DR
INE
W/
CO
D-G
G S
OLN
C
HE
RA
TU
SS
IN D
AC
OR
AL
NO
B4
SN
AR
C A
NT
ITU
SS
-EX
PE
CT
OR
AN
T C
MB
GU
AIF
EN
ES
IN W
/CO
DE
INE
GU
AIF
EN
ES
IN W
/CO
DE
INE
OR
AL
NO
B4
DN
AR
C A
NT
ITU
SS
IVE
-AN
TIH
IST
CM
BC
HLO
RP
HE
NIR
AM
INE
W/
HY
DR
OC
OD
ON
E
CR
SU
SP
T
US
SIO
NE
XO
RA
LN
OH
YD
RO
CO
D P
OLS
T-C
HLO
RP
HE
N P
OLS
T C
AP
SR
T
US
SIC
AP
SO
RA
LN
O
PR
OM
ET
HA
ZIN
E-C
OD
EIN
EP
RO
ME
TH
AZ
INE
-CO
DE
INE
OR
AL
NO
H3
MN
AR
C-N
ON
-SA
L A
NLG
-BA
RB
IT-X
AN
TH
BU
TA
LBIT
AL-
AP
AP
-CA
FF
W/
CO
DF
IOR
ICE
T W
/CO
DE
INE
OR
AL
NO
H3
XN
AR
CO
TIC
AN
ALG
/SA
LIC
YLA
TE
CO
MB
AS
PIR
IN W
ITH
CO
DE
INE
AS
PIR
IN W
ITH
CO
DE
INE
OR
AL
NO
H3
NN
AR
CO
TIC
AN
ALG
ES
IC/N
SA
ID C
OM
BO
HY
DR
OC
OD
ON
E-I
BU
PR
OF
EN
VIC
OP
RO
FE
NO
RA
LN
O
OX
YC
OD
ON
E-I
BU
PR
OF
EN
CO
MB
UN
OX
OR
AL
NO
H3
AN
AR
CO
TIC
AN
ALG
ES
ICS
AP
AP
-CA
FF
EIN
E-D
IHY
DR
OC
OD
EIN
ES
YN
ALG
OS
-DC
OR
AL
NO
CO
DE
INE
SU
LFA
TE
CO
DE
INE
SU
LFA
TE
OR
AL
NO
FE
NT
AN
YL
CIT
RA
TE
AC
TIQ
BU
CC
AL
NO
Cla
im m
ust
be
all
ow
ed
fo
r n
eo
pla
sm o
r m
ali
gn
an
cy (
bu
cca
l fo
rmu
lati
on
s o
nly
)
FE
NT
AN
YL
CIT
RA
TE
F
EN
TO
RA
BU
CC
AL
NO
Cla
im m
ust
be
all
ow
ed
fo
r n
eo
pla
sm o
r m
ali
gn
an
cy (
bu
cca
l fo
rmu
lati
on
s o
nly
)
FE
NT
AN
YL
TD
DU
RA
GE
SIC
TR
AN
SD
ER
MN
O
HY
DR
OC
OD
ON
E-A
CE
TA
MIN
OP
HE
NV
ICO
DIN
OR
AL
NO
All
str
en
gth
s a
nd
ora
l fo
rmu
lati
on
s o
f a
ceta
min
op
he
n a
nd
hy
dro
cod
on
e a
re
cov
ere
d
HY
DR
OM
OR
PH
ON
E H
CL
DIL
AU
DID
OR
AL
NO
LEV
OR
PH
AN
OL
TA
RT
RA
TE
LEV
O-D
RO
MO
RA
NO
RA
LN
O
ME
PE
RID
INE
HC
LD
EM
ER
OL
OR
AL
NO
ME
PE
RID
INE
-PR
OM
ET
HA
ZIN
EM
EP
ER
GA
NO
RA
LN
O
ME
TH
AD
ON
E H
CL
DO
LOP
HIN
EO
RA
LN
O
MO
RP
HIN
E S
ULF
AT
EA
VIN
ZA
OR
AL
NO
MO
RP
HIN
E S
ULF
AT
EK
AD
IAN
OR
AL
NO
MO
RP
HIN
E-N
ALT
RE
XO
NE
EM
BE
DA
OR
AL
NO
OP
IUM
TIN
CT
UR
E
PA
RE
GO
RIC
OR
AL
NO
OX
YC
OD
ON
E H
CL
OX
Y I
R,
OX
YC
ON
TIN
OR
AL
NO
OX
YC
OD
ON
E W
/ A
CE
TA
MIN
OP
HE
N
PE
RC
OC
ET
OR
AL
NO
All
str
en
gth
s a
nd
ora
l fo
rmu
lati
on
s o
f a
ceta
min
op
he
n a
nd
oxy
cod
on
e a
re c
ov
ere
d
OX
YC
OD
ON
E W
/ A
SP
IRIN
PE
RC
OD
AN
OR
AL
NO
OX
YM
OR
PH
ON
E H
CL
OP
AN
A,
OP
AN
A E
RO
RA
LN
O
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
29
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
H3
BN
AR
CO
TIC
AN
ALG
ES
ICS
(C
ON
T)
BU
TO
RP
HA
NO
L T
AR
TR
AT
ES
TA
DO
L N
AS
AL
NA
SA
LN
O
PE
NT
AZ
OC
INE
- A
CE
TA
MIN
OP
HE
NT
ALA
CE
NO
RA
LN
O
PE
NT
AZ
OC
INE
AN
D N
ALO
XO
NE
HC
LT
ALW
IN N
XO
RA
LN
O
TA
PE
NT
AD
OL
HC
L N
UC
YN
TA
OR
AL
NO
TR
AM
AD
OL
HC
LU
LTR
AM
OR
AL
NO
TR
AM
AD
OL-
AC
ET
AM
INO
PH
EN
ULT
RA
CE
TO
RA
LN
O
H3
YN
AR
CO
TIC
AN
TA
G,
PE
RIP
H-A
CT
ING
ME
TH
YLN
ALT
RE
XO
NE
BR
OM
IDE
RE
LIS
TO
RS
UB
-QN
O
H3
TN
AR
CO
TIC
AN
TA
GO
NIS
TS
NA
LTR
EX
ON
E H
CL
RE
VIA
OR
AL
NO
H3
UN
AR
CO
TIC
+N
ON
-SA
LIC
AN
ALG
CO
MB
O
AC
ET
AM
INO
PH
EN
-CO
DE
INE
TY
LEN
OL
W/C
OD
EIN
E N
O.3
OR
AL
NO
H3
RN
AR
C-S
ALI
C A
NLG
-BA
RB
-XA
NT
HIN
E
BU
TA
LBIT
AL-
AS
PIR
IN-C
AF
F W
/ C
OD
EIN
EF
IOR
INA
L W
ITH
CO
DE
INE
#3
OR
AL
NO
Q7
EN
AS
AL
AN
TIH
IST
AM
INE
AZ
ELA
ST
INE
HC
LA
ST
ELI
NN
AS
AL
YE
S
OLO
PA
TA
DIN
E H
CL
PA
TA
NA
SE
NA
SA
LY
ES
Q7
HN
AS
AL
MA
ST
CE
LL S
TA
BIL
IZE
RS
CR
OM
OLY
N S
OD
IUM
N
AS
ALC
RO
MN
AS
AL
YE
S
C6
NN
IAC
IN P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
NIA
CIN
N
IAC
INO
RA
LY
ES
W2
FN
ITR
OF
UR
AN
DE
RIV
AT
IVE
S
NIT
RO
FU
RA
NT
OIN
MA
CR
OD
AN
TIN
OR
AL
NO
H2
EN
ON
-BA
RB
ITU
RA
TE
, S
ED
AT
IVE
CH
LOR
AL
HY
DR
AT
EC
HLO
RA
L H
YD
RA
TE
OR
AL
NO
CH
LOR
AL
HY
DR
AT
EN
OC
TE
CO
RA
LN
O
DIP
HE
NH
YD
RA
MIN
E H
CL
DIP
HE
NH
YD
RA
MIN
E H
CL
OR
AL
NO
DO
XE
PIN
HC
LD
OX
EP
IN H
CL
(SLE
EP
) T
AB
OR
AL
NO
ES
TA
ZO
LAM
PR
OS
OM
OR
AL
NO
ES
ZO
PIC
LON
ELU
NE
ST
AO
RA
LN
O
FLU
RA
ZE
PA
M H
CL
DA
LMA
NE
OR
AL
NO
TE
MA
ZE
PA
M
RE
ST
OR
ILO
RA
LN
O
TR
IAZ
OLA
MH
ALC
ION
OR
AL
NO
ZA
LEP
LON
SO
NA
TA
OR
AL
NO
ZO
LPID
EM
TA
RT
RA
TE
A
MB
IEN
OR
AL
NO
ZO
LPID
EM
TA
RT
RA
TE
SL
ED
LUA
RS
UB
LIN
GU
AL
NO
B4
EN
ON
-NA
RC
AN
TIT
US
S-A
NT
IHS
TC
MB
CA
R-B
-PE
N T
A/C
HLO
R-T
AN
CA
R-B
-PE
N T
A/C
HLO
R-T
AN
OR
AL
NO
CH
LOR
PH
EN
IRA
MIN
E-D
MC
HLO
RP
HE
NIR
AM
INE
-DM
OR
AL
NO
PR
OM
ET
HA
ZIN
E-D
MP
RO
ME
TH
AZ
INE
-DM
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
30
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
B4
RN
ON
-NA
RC
AN
TIT
US
S-D
EC
ON
G-E
XP
CT
NO
PH
EN
YLE
PH
RIN
E W
/ D
M-G
GR
OB
ITU
SS
IN C
OU
GH
& C
OLD
CF
OR
AL
NO
PS
EU
DO
EP
HE
DR
INE
W/
DM
-GG
TA
BC
AP
MIS
T D
MO
RA
LN
O
H3
KN
ON
-SA
L A
NA
LG-B
AR
BIT
UR
AT
E C
MB
BU
TA
LBIT
AL-
AC
ET
AM
INO
PH
EN
P
HR
EN
ILIN
OR
AL
NO
H3
LN
ON
-SA
L A
NA
LG-B
AR
BIT
-XA
NT
HIN
E
BU
TA
LBIT
AL-
AP
AP
-CA
FF
EIN
E
FIO
RIC
ET
OR
AL
NO
H7
DN
OR
EP
INE
PH
/DO
PA
MIN
E R
EU
P I
NH
IB
BU
PR
OP
ION
HB
R
AP
LEN
ZIN
OR
AL
NO
BU
PR
OP
ION
HC
LW
ELL
BU
TR
INO
RA
LN
O
Q7
WN
OS
E P
RE
PS
AN
TIB
IOT
ICS
MU
PIR
OC
IN C
ALC
IUM
B
AC
TR
OB
AN
NA
SA
LN
AS
AL
YE
S
Q7
PN
OS
E P
RE
PS
AN
TII
NF
LAM
MA
TO
RY
BE
CLO
ME
TH
AS
ON
E D
IPR
OP
ION
AT
E
BE
CO
NA
SE
AQ
NA
SA
LY
ES
BU
DE
SO
NID
E
RH
INO
CO
RT
AQ
UA
NA
SA
LY
ES
CIC
LES
ON
IDE
OM
NA
RIS
NA
SA
LY
ES
FLU
NIS
OLI
DE
F
LUN
ISO
LID
EN
AS
AL
YE
S
FLU
TIC
AS
ON
E F
UR
OA
TE
VE
RA
MY
ST
NA
SA
LY
ES
FLU
TIC
AS
ON
E P
RO
PIO
NA
TE
F
LON
AS
EN
AS
AL
YE
S
MO
ME
TA
SO
NE
FU
RO
AT
E
NA
SO
NE
XN
AS
AL
YE
S
TR
IAM
CIN
OLO
NE
AC
ET
ON
IDE
NA
SA
CO
RT
AQ
NA
SA
LY
ES
Q7
YN
OS
E P
RE
PS
MIS
C O
TC
ON
LY
SA
LIN
ES
EA
SO
FT
NA
SA
LY
ES
Q7
AN
OS
E P
RE
PS
MIS
C R
X O
NLY
IPR
AT
RO
PIU
M B
RO
MID
EIP
RA
TR
OP
IUM
BR
OM
IDE
NA
SA
LY
ES
Q7
DN
OS
E P
RE
PS
VA
SO
CO
NS
TR
ICT
OR
S
OX
YM
ET
AZ
OLI
NE
HC
L1
2 H
OU
R N
AS
AL
SP
RA
YN
AS
AL
YE
S
PH
EN
YLE
PH
RIN
E H
CL
NE
O-S
YN
EP
HR
INE
NA
SA
LY
ES
S2
TN
SA
ID &
PR
OS
TA
GLA
ND
IN C
OM
BO
DIC
LOF
EN
AC
W/
MIS
OP
RO
ST
OL
AR
TH
RO
TE
C 5
0O
RA
LN
O
S2
PN
SA
ID &
PR
OT
ON
PU
MP
IN
HIB
CO
MB
Ina
ctiv
eP
RE
VA
CID
NA
PR
AP
AC
OR
AL
NO
S2
SN
SA
ID-1
ST
GE
N A
NT
IHIS
T-S
ED
AT
IVE
IBU
PR
OF
EN
-DIP
HE
NH
YD
RA
MIN
E
AD
VIL
PM
OR
AL
NO
S2
BN
SA
IDS
CE
LEC
OX
IBC
ELE
BR
EX
OR
AL
NO
DIC
LOF
EN
AC
PO
TA
SS
IUM
DIC
LOF
EN
AC
PO
TA
SS
IUM
OR
AL
NO
DIC
LOF
EN
AC
SO
DIU
MV
OLT
AR
EN
OR
AL
NO
ET
OD
OLA
CE
TO
DO
LAC
OR
AL
NO
FE
NO
PR
OF
EN
CA
LCIU
MF
EN
OP
RO
FE
N C
ALC
IUM
OR
AL
NO
FE
NO
PR
OF
EN
CA
LCIU
M
NA
LFO
NO
RA
LN
O
FLU
RB
IPR
OF
EN
FLU
RB
IPR
OF
EN
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
31
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
NS
AID
S (
CO
NT
)IB
UP
RO
FE
NM
OT
RIN
OR
AL
NO
IND
OM
ET
HA
CIN
IND
OM
ET
HA
CIN
OR
AL
NO
KE
TO
PR
OF
EN
KE
TO
PR
OF
EN
OR
AL
NO
KE
TO
RO
LAC
TR
OM
ET
HA
MIN
EK
ET
OR
OLA
C T
RO
ME
TH
AM
INE
OR
AL
NO
Qu
an
tity
ma
y n
ot
exc
ee
d 2
0 u
nit
s o
r a
5 d
ay
su
pp
ly w
hic
he
ve
r is
le
ast
du
rin
g a
roll
ing
12
mo
nth
pe
rio
d.
ME
CLO
FE
NA
MA
TE
SO
DIU
MM
EC
LOF
EN
AM
AT
E S
OD
IUM
OR
AL
NO
NA
BU
ME
TO
NE
NA
BU
ME
TO
NE
OR
AL
NO
NA
PR
OX
EN
SO
DIU
M
NA
PR
OX
EN
OR
AL
NO
NA
PR
OX
EN
-ES
OM
EP
RA
ZO
LE M
AG
NE
SIU
MN
AP
RO
XE
N-E
SO
ME
PR
AZ
OLE
MA
GN
ES
IUM
OR
AL
NO
PIR
OX
ICA
MP
IRO
XIC
AM
OR
AL
NO
SU
LIN
DA
C
SU
LIN
DA
CO
RA
LN
O
TO
LME
TIN
SO
DIU
MT
OLM
ET
IN S
OD
IUM
OR
AL
NO
S2
DN
SA
IDS
(C
ON
T-A
)
ME
FE
NA
MIC
AC
IDM
EF
EN
AM
IC A
CID
OR
AL
NO
ME
FE
NA
MIC
AC
IDP
ON
ST
EL
OR
AL
NO
OX
AP
RO
ZIN
OX
AP
RO
ZIN
OR
AL
NO
S2
EN
SA
IDS
(C
ON
T-B
)
ME
LOX
ICA
MM
OB
ICO
RA
LN
O
S2
RN
SA
IDS
/DIE
TA
RY
SU
PP
CO
MB
O
Ina
ctiv
eIC
80
0O
RA
LN
O
U6
EO
INT
ME
NT
/CR
EA
M B
AS
ES
EM
OLL
IEN
TD
IAB
ET
IDE
RM
TO
PIC
AL
NO
VA
SE
LIN
E P
ET
RO
LEU
MV
AS
ELI
NE
PE
TR
OLE
UM
TO
PIC
AL
NO
Q2
CO
PH
TH
AN
TI-
INF
LAM
IM
MU
NO
MO
DU
LA
CY
CLO
SP
OR
INE
(O
PH
TH
)R
ES
TA
SIS
OP
HT
HA
LMIC
YE
S
Q6
UO
PH
TH
ALM
IC M
AS
T C
ELL
ST
AB
CR
OM
OLY
N S
OD
IUM
CR
OM
OLY
N S
OD
IUM
OP
HT
HA
LMIC
YE
S
M9
LO
RA
L A
NT
ICO
AG
ULA
NT
S,
CO
UM
AR
I
WA
RF
AR
IN S
OD
IUM
C
OU
MA
DIN
OR
AL
NO
D4
HO
RA
L M
UC
OS
ITIS
/ST
OM
AT
ITIS
AG
PO
VID
ON
E-S
OD
IUM
HY
ALU
RO
NA
TE
-
GLY
CY
RR
HE
TIN
IC A
CID
GE
LCLA
IRM
UC
OU
S M
EM
NO
Q8
FO
TIC
PR
EP
AR
AT
ION
S A
NT
I IN
FLA
CIP
RO
FLO
XA
CIN
-HY
DR
OC
OR
TIS
ON
EC
IPR
O H
CO
TIC
NO
W1
OO
XA
ZO
LDIN
ON
ES
LIN
EZ
OLI
DZ
YV
OX
OR
AL
NO
W8
DO
XID
IZIN
G A
GE
NT
S
DA
KIN
'S S
OLU
TIO
ND
AK
IN'S
MIS
CE
LLN
O
HY
DR
OG
EN
PE
RO
XID
EH
YD
RO
GE
N P
ER
OX
IDE
MIS
CE
LLN
O
G3
AO
XY
TO
CIC
S
ME
TH
YLE
RG
ON
OV
INE
MA
LEA
TE
ME
TH
ER
GIN
EO
RA
LN
O
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
32
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
D8
AP
AN
CR
EA
TIC
EN
ZY
ME
SA
ll o
ral
form
ula
tio
ns
of
the
se d
rug
s a
re c
ov
ere
d f
or
all
ow
ed
co
nd
itio
ns
AM
Y-L
IP-P
RO
T
PA
NC
RE
AS
E M
T 1
0O
RA
LY
ES
AM
Y-L
IP-P
RO
T
PA
NC
RE
LIP
AS
E (
LIP
-PR
OT
-AM
YL)
DR
CA
PO
RA
LY
ES
PA
NC
RE
LIP
AS
E (
LIP
-PR
OT
-AM
YL)
CR
EO
NO
RA
LY
ES
J1A
PA
RA
SY
MP
AT
HE
TIC
AG
EN
TS
BE
TH
AN
EC
HO
L C
HLO
RID
EU
RE
CH
OLI
NE
OR
AL
NO
CE
VIM
ELI
NE
HC
L E
VO
XA
CO
RA
LN
O
PIL
OC
AR
PIN
E H
CL
PIL
OC
AR
OR
AL
NO
C6
HP
ED
IAT
RIC
VIT
AM
IN P
RE
PA
RE
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
sP
ED
IAT
RIC
MU
LTIP
LE V
ITA
MIN
W/
MIN
ER
ALS
& C
CH
EW
C
ER
OV
ITE
JR
OR
AL
YE
S
W1
AP
EN
ICIL
LIN
S
AM
OX
ICIL
LIN
AM
OX
ICIL
LIN
OR
AL
NO
AM
OX
ICIL
LIN
& K
CLA
VU
LAN
AT
E
AU
GM
EN
TIN
OR
AL
NO
AM
OX
ICIL
LIN
(T
RIH
YD
RA
TE
)M
OX
AT
AG
OR
AL
NO
AM
PIC
ILLI
N T
RIH
YD
RA
TE
AM
PIC
ILLI
N T
RIH
YD
RA
TE
OR
AL
NO
DIC
LOX
AC
ILLI
N S
OD
IUM
DIC
LOX
AC
ILLI
N S
OD
IUM
OR
AL
NO
Ina
ctiv
eG
EO
CIL
LIN
OR
AL
NO
PE
NIC
ILLI
N V
PO
TA
SS
IUM
PE
NIC
ILLI
N V
PO
TA
SS
IUM
OR
AL
NO
D1
AP
ER
IOD
ON
TIA
L C
OLL
IN
HIB
ITO
RS
DO
XY
CY
CLI
NE
HY
CLA
TE
DO
XY
CY
CLI
NE
HY
CLA
TE
OR
AL
YE
S
A7
CP
ER
IPH
ER
AL
VA
SO
DIL
AT
OR
S
ISO
XS
UP
RIN
E H
CL
VA
SO
DIL
AN
OR
AL
YE
S
PA
PA
VE
RIN
E H
CL
PA
VA
BID
OR
AL
YE
S
C1
PP
HO
SP
AT
E R
EP
LAC
ME
NT
PH
OS
PA
TE
RE
PLA
CM
EN
TP
OT
AS
SIU
M &
SO
DIU
M P
HO
SP
HA
TE
SN
EU
TR
A-P
HO
SO
RA
LY
ES
M9
PP
LAT
ELE
T A
GG
RE
GA
TIO
N I
NH
IBIT
AS
PIR
IN-D
IPY
RID
AM
OLE
AG
GR
EN
OX
OR
AL
YE
S
CIL
OS
TA
ZO
LC
ILO
ST
AZ
OL
OR
AL
YE
S
CLO
PID
OG
RE
L B
ISU
LFA
TE
PLA
VIX
OR
AL
YE
S
DIP
YR
IDA
MO
LED
IPY
RID
AM
OLE
OR
AL
YE
S
PE
RS
AN
TIN
EP
ER
SA
NT
INE
OR
AL
YE
S
TIC
LOP
IDIN
E H
CL
TIC
LOP
IDIN
E H
CL
OR
AL
YE
S
B1
BP
LUM
AN
TIH
YP
ER
TE
N E
ND
O R
EC
AN
T
AM
BR
ISE
NT
AN
LET
AIR
ISO
RA
LY
ES
BO
SE
NT
AN
TR
AC
LEE
RO
RA
LY
ES
C1
DP
OT
AS
SIU
M R
EP
LAC
EM
EN
TA
ll p
ota
ssiu
m s
alt
s a
nd
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d c
on
dit
ion
s
PO
TA
SS
IUM
BIC
AR
BO
NA
TE
EF
FE
R
KLO
R-C
ON
-EF
OR
AL
YE
S
PO
TA
SS
IUM
CH
LOR
IDE
K
LOR
-CO
NO
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
33
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
R1
HP
OT
AS
SIU
M S
PA
RIN
G D
IUR
ET
ICS
R1
LP
OT
AS
SIU
M S
PA
RIN
G D
IUR
ET
ICS
AM
ILO
RID
E H
CL
AM
ILO
RID
E H
CL
OR
AL
YE
S
AM
ILO
RID
E H
CL-
HC
TZ
AM
ILO
RID
E H
CL-
HC
TZ
OR
AL
YE
S
EP
LER
EN
ON
EIN
SP
RA
OR
AL
YE
S
SP
IRO
NO
LAC
TO
NE
ALD
AC
TO
NE
OR
AL
YE
SS
PIR
ON
OLA
CT
ON
E &
HY
DR
OC
HLO
RO
TH
IAZ
IDE
A
LDA
CT
AZ
IDE
OR
AL
YE
S
SP
IRO
NO
LAC
TO
NE
-HC
TZ
SP
IRO
NO
LAC
TO
NE
-HC
TZ
OR
AL
YE
S
TR
IAM
TE
RE
NE
& H
YD
RO
CH
LOR
OT
HIA
ZID
ED
YA
ZID
EO
RA
LY
ES
TR
IAM
TE
RE
NE
W/H
CT
ZT
RIA
MT
ER
EN
E W
/HC
TZ
OR
AL
YE
S
C6
FP
RE
NA
TA
L V
ITA
MIN
PR
EP
AR
AT
ION
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
PR
EN
AT
AL
VIT
W/
DS
S-F
E F
UM
AR
AT
E-F
AP
RE
NA
TA
L 1
9O
RA
LY
ES
PR
EN
AT
AL
VIT
W/
FE
FU
MA
RA
TE
-FA
P
RE
NA
TA
L P
LUS
OR
AL
YE
S
G2
AP
RO
GE
ST
AT
ION
AL
AG
EN
TS
ME
DR
OX
YP
RO
GE
ST
ER
ON
E A
CE
TA
TE
ME
DR
OX
YP
RO
GE
ST
ER
ON
E A
CE
TA
TE
OR
AL
YE
S
L3A
PR
OT
EC
TIV
ES
L3B
PR
OT
EC
TIV
ES
ALU
MIN
UM
HY
DR
OX
IDE
DE
RM
AG
RA
NT
OP
ICA
LN
O
BE
NZ
OIN
BE
NZ
OIN
TO
PIC
AL
NO
DE
RM
AT
OLO
GIC
AL
PR
OD
UC
TS
MIS
CT
ET
RIX
TO
PIC
AL
NO
DIM
ET
HIC
ON
EP
RO
SH
IELD
PLU
ST
OP
ICA
LN
O
DIM
ET
HIC
ON
E
PA
CQ
UIN
ME
DIC
AT
ED
TO
PIC
AL
NO
HY
ALU
RO
NA
TE
SO
DIU
M
BIO
NE
CT
TO
PIC
AL
NO
HY
ALU
RO
NA
TE
SO
DIU
M (
EM
OLL
IEN
T)
HY
LIR
AT
OP
ICA
LN
O
ME
NT
HO
L-Z
INC
OX
IDE
CA
LMO
SE
PT
INE
TO
PIC
AL
NO
PE
TR
OLA
TU
M-Z
INC
OX
IDE
SE
NS
I-C
AR
ET
OP
ICA
LN
O
PE
TR
OLA
TU
M-Z
INC
OX
IDE
SE
NS
I-C
AR
ET
OP
ICA
LN
O
SK
IN P
RO
TE
CT
AN
TS
MIS
CP
ELE
VE
RU
S G
OLD
TO
PIC
AL
NO
SK
IN P
RO
TE
CT
AN
TS
MIS
C
ALO
E V
ES
TA
TO
PIC
AL
NO
SO
DIU
M H
YA
LUR
ON
AT
ES
OD
IUM
HY
ALU
RO
NA
TE
TO
PIC
AL
NO
TA
LC T
OP
ICA
L P
OW
DE
R
T
ALC
TO
PIC
AL
PO
WD
ER
TO
PIC
AL
NO
TIN
CT
UR
E O
F B
EN
ZO
INT
INC
TU
RE
OF
BE
NZ
OIN
TO
PIC
AL
NO
PR
OT
EC
TIV
ES
(C
ON
T)
WO
UN
D C
LEA
NS
ER
SP
ELE
VE
RU
ST
OP
ICA
LN
O
ZIN
C O
XID
ED
ES
ITIN
TO
PIC
AL
NO
ZIN
C O
XID
EB
OU
DR
EA
UX
ST
OP
ICA
LN
O
D4
JP
RO
TO
N P
UM
P I
NH
IBIT
OR
S
ES
OM
EP
RA
ZO
LE M
AG
NE
SIU
M
NE
XIU
MO
RA
LN
O
LAN
SO
PR
AZ
OLE
P
RE
VA
CID
OR
AL
NO
OM
EP
RA
ZO
LEP
RIL
OS
EC
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
34
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
PR
OT
ON
PU
MP
IN
HIB
ITO
RS
(C
ON
T)
OM
EP
RA
ZO
LE-S
OD
IUM
BIC
AR
BO
NA
TE
ZE
GE
RID
OR
AL
NO
PA
NT
OP
RA
ZO
LE S
OD
IUM
PR
OT
ON
IXO
RA
LN
O
RA
BE
PR
AZ
OLE
SO
DIU
M
AC
IPH
EX
OR
AL
NO
B1
DP
ULM
ON
AR
Y A
NT
IHY
PE
RT
EN
SIV
ES
SIL
DE
NA
FIL
CIT
RA
TE
(P
ulm
on
ary
)R
EV
AT
IOO
RA
LY
ES
C7
AP
UR
INE
IN
HIB
ITO
RS
ALL
OP
UR
INO
L A
LLO
PU
RIN
OL
OR
AL
YE
S
FE
BU
XO
ST
AT
ULO
RIC
OR
AL
YE
S
S2
IP
YR
IMID
INE
SY
NT
HE
SIS
IN
HIB
ITR
LEF
LUN
OM
IDE
LEF
LUN
OM
IDE
OR
AL
YE
S
W1
UIN
OLO
NE
S
CIP
RO
FLO
XA
CIN
HC
LC
IPR
OO
RA
LN
O
GE
MIF
LOX
AC
IN M
ES
YLA
TE
FA
CT
IVE
OR
AL
NO
LEV
OF
LOX
AC
INLE
VA
QU
INO
RA
LN
O
MO
XIF
LOX
AC
IN H
CL
AV
ELO
XO
RA
LN
O
NO
RF
LOX
AC
IN
NO
RO
XIN
OR
AL
NO
OF
LOX
AC
INO
FLO
XA
CIN
OR
AL
NO
Q3
BR
EC
TA
L LO
WE
R B
OW
EL
PR
EP
HY
DR
OC
OR
TIS
ON
E
CO
LOC
OR
TR
EC
TA
LY
ES
HY
DR
OC
OR
TIS
ON
E A
CE
TA
TE
C
OR
TIF
OA
MR
EC
TA
LY
ES
Q3
AR
EC
TA
L P
RE
PA
RA
TIO
NS
HY
DR
OC
OR
TIS
ON
EP
RO
CT
OC
OR
TR
EC
TA
LN
OH
YD
RO
CO
RT
ISO
NE
AC
ET
AT
E W
/
PR
AM
OX
INE
P
RO
CT
OF
OA
M-H
CR
EC
TA
LN
O
ST
AR
CH
T
UC
KS
RE
CT
AL
NO
A4
UR
EN
IN I
NH
IB/T
HIA
ZID
E D
IUR
ET
IC
ALI
SK
IRE
N-H
CT
ZT
EK
TU
RN
A H
CT
OR
AL
NO
A4
TR
EN
IN I
NH
IBIT
OR
, D
IRE
CT
ALI
SK
IRE
N F
UM
AR
AT
ET
EK
TU
RN
AO
RA
LY
ES
A4
WR
EN
IN-I
NH
/AN
GIO
TE
NS
IN-R
EC
-AN
T
ALI
SK
IRE
N-V
ALS
AR
TA
NV
ALT
UR
NA
OR
AL
NO
W9
CR
IFA
MY
CIN
S/R
ELA
TE
D A
NT
IBIO
TIC
S
RIF
AX
IMIN
XIF
AX
AN
OR
AL
NO
L5G
RO
SA
CE
A A
GE
NT
S,
TO
PIC
AL
ME
TR
ON
IDA
ZO
LEM
ET
RO
GE
LT
OP
ICA
LY
ES
H3
OS
ALI
CY
L A
NLG
-BA
RB
ITU
R-X
AN
TH
INE
BU
TA
LBIT
AL-
AS
PIR
IN-C
AF
FE
INE
F
IOR
INA
LO
RA
LN
O
H3
DS
ALI
CY
LAT
E A
NA
LGE
SIC
S
AC
ET
AM
INO
PH
EN
-SA
LIC
YLA
MID
E-
PH
EN
YLT
OLO
XA
MIN
EB
E-F
LEX
PLU
SO
RA
LN
OA
PA
P-S
ALI
CY
LAM
IDE
-PH
EN
YLT
OLO
X-
CA
FF
EIN
E
DU
RA
BA
CO
RA
LN
O
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
35
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
SA
LIC
YLA
TE
AN
ALG
ES
ICS
(C
ON
T)
AS
PIR
INA
SP
IRIN
OR
AL
NO
AS
PIR
IN B
UF
FE
RE
D (
CA
CA
RB
-MG
CA
RB
-MG
OX
)B
UF
FE
RIN
OR
AL
NO
AS
PIR
IN W
/AN
TA
CID
AS
PIR
IN W
/AN
TA
CID
OR
AL
NO
AS
PIR
IN-A
CE
TA
MIN
OP
HE
N-C
AF
FE
INE
EX
CE
DR
INO
RA
LN
O
AS
PIR
IN-A
L H
YD
RO
-MG
HY
DR
O-C
A C
AR
BA
SC
RIP
TIN
OR
AL
NO
AS
PIR
IN-A
PA
P-S
ALI
CY
LAM
IDE
-CA
FF
EIN
E
LEV
AC
ET
OR
AL
NO
AS
PIR
IN-C
AF
FE
INE
AN
AC
INO
RA
LN
O
CH
OLI
NE
MA
G T
RIS
ALI
CY
LAT
ET
RIL
ISA
TE
OR
AL
NO
DIF
LUN
ISA
LD
OLO
BID
OR
AL
NO
ME
PR
OB
AM
AT
E-A
SP
IRIN
EQ
UA
GE
SIC
OR
AL
NO
SA
LSA
LAT
ED
ISA
LCID
OR
AL
NO
D4
LS
ALI
VA
SU
BS
TIT
UT
E A
GE
NT
S
AR
TIF
ICIA
L S
ALI
VA
A
QU
OR
AL
MU
CO
US
ME
MN
O
MIS
C T
HR
OA
T P
RO
DU
CT
SO
AS
ISM
UC
OU
S M
EM
NO
V1
TS
EL
ES
TR
OG
EN
RE
CE
PT
MO
DU
LAT
OR
S
TA
MO
XIF
EN
CIT
RA
TE
TA
MO
XIF
EN
CIT
RA
TE
OR
AL
YE
S
H7
ES
ER
OT
ON
IN-2
AN
TA
G/R
EU
P I
NH
IB
NE
FA
ZO
DO
NE
HC
LN
EF
AZ
OD
ON
E H
CL
OR
AL
NO
TR
AZ
AD
ON
E H
CL
TR
AZ
OD
ON
E H
CL
OR
AL
NO
H7
CS
ER
OT
ON
IN-N
OR
EP
INE
PH
RE
UP
IN
HI
DE
SV
EN
LAF
AX
INE
SU
CC
INA
TE
P
RIS
TIQ
OR
AL
NO
DU
LOX
ET
INE
HC
L C
YM
BA
LTA
OR
AL
NO
VE
NLA
FA
XIN
E H
CL
EF
FE
XO
RO
RA
LN
O
H2
SS
ER
TO
NIN
SP
EC
RE
UP
IN
HIB
-SS
RI
CIT
ALO
PR
AM
HY
DR
OB
RO
MID
E
CE
LEX
AO
RA
LN
O
ES
CIT
ALO
PR
AM
OX
ALA
TE
LE
XA
PR
OO
RA
LN
O
FLU
OX
ET
INE
HC
LP
RO
ZA
CO
RA
LN
OA
ll o
ral
form
ula
tio
ns
an
d s
tre
ng
ths
are
co
ve
red
FLU
VO
XA
MIN
E M
ALE
AT
E
LUV
OX
CR
OR
AL
NO
PA
RO
XE
TIN
E H
CL
PA
XIL
OR
AL
NO
PA
RO
XE
TIN
E M
ES
YLA
TE
P
EX
EV
AO
RA
LN
O
SE
RT
RA
LIN
E H
CL
ZO
LOF
TO
RA
LN
O
L7A
SH
AM
PO
OS
INF
AN
T C
AR
E P
RO
DU
CT
SB
AB
Y S
HA
MP
OO
TO
PIC
AL
NO
H6
HS
KE
LET
AL
MU
SC
LE R
ELA
XA
NT
SE
xclu
din
g B
acl
ofe
n a
nd
Da
ntr
ole
ne
, a
ge
nts
in
th
is c
lass
are
U6
JS
OLV
EN
TS
U6
KS
OLV
EN
TS
MIN
ER
AL
OIL
MIN
ER
AL
OIL
MIS
CE
LLN
O
RU
BB
ING
ALC
OH
OL
RU
BB
ING
ALC
OH
OL
MIS
CE
LLN
O
H7
ZS
SR
I/A
NT
IPS
YC
HO
TIC
, C
OM
BIN
AT
IO
OLA
NZ
AP
INE
-FLU
OX
ET
INE
HC
LS
YM
BY
AX
OR
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
36
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
V1
ES
TE
RO
ID A
NT
INE
OP
LAS
TIC
S
ME
GE
ST
RO
L A
CE
TA
TE
ME
GE
ST
RO
L A
CE
TA
TE
OR
AL
YE
S
L5B
SU
NS
CR
EE
NS
SU
NS
CR
EE
N L
OT
ION
TO
TA
L B
LOC
KT
OP
ICA
LN
O
J5E
SY
MP
AT
HO
MIM
ET
IC A
GE
NT
S
PH
EN
YLE
PH
RIN
E H
CL
NE
O-S
YN
EP
HR
INE
OR
AL
NO
PS
EU
DO
EP
HE
DR
INE
HC
LS
UD
AF
ED
OR
AL
NO
H2
XT
CA
/BE
NZ
OD
IAZ
EP
INE
CO
MB
IN
AM
ITR
IPT
YLI
NE
-CH
LOR
DIA
ZE
PO
XID
EA
MIT
RIP
TY
LIN
E-C
HLO
RD
IAZ
EP
OX
IDE
OR
AL
NO
H2
WT
CA
/PH
EN
OT
HIA
ZIN
E C
OM
BIN
AT
ION
PE
RP
HE
NA
ZIN
E-A
MIT
RIP
TY
LIN
EP
ER
PH
EN
AZ
INE
-AM
ITR
IPT
YLI
NE
OR
AL
NO
W1
CT
ET
RA
CY
LIN
ES
DE
ME
CLO
CY
CLI
NE
HC
LD
EM
EC
LOC
YC
LIN
E H
CL
OR
AL
NO
DO
XY
CY
CLI
NE
DO
XY
CY
CLI
NE
OR
AL
NO
DO
XY
CY
CLI
NE
(R
OS
AC
EA
)O
RA
CE
AO
RA
LN
O
DO
XY
CY
CLI
NE
HY
CLA
TE
DO
RY
XO
RA
LN
O
DO
XY
CY
CLI
NE
MO
NO
HY
DR
AT
ED
OX
YC
YC
LIN
E M
ON
OH
YD
RA
TE
OR
AL
NO
MIN
OC
YC
LIN
E H
CL
SO
LOD
YN
OR
AL
NO
TE
TR
AC
YC
LIN
E H
CL
TE
TR
AC
YC
LIN
E H
CL
OR
AL
NO
R1
FT
HIA
ZID
E D
IUR
ET
ICS
AN
D R
ELA
CH
LOR
OT
HIA
ZID
EC
HLO
RO
TH
IAZ
IDE
OR
AL
YE
S
HY
DR
OC
HLO
RO
TH
IAZ
IDE
HY
DR
OC
HLO
RO
TH
IAZ
IDE
OR
AL
YE
S
IND
AP
AM
IDE
IND
AP
AM
IDE
OR
AL
YE
S
ME
TO
LAZ
ON
EM
ET
OLA
ZO
NE
OR
AL
YE
S
P3
AT
HY
RO
ID H
OR
MO
NE
S
LEV
OT
HY
RO
XIN
E S
OD
IUM
S
YN
TH
RO
IDO
RA
LY
ES
LIO
TH
YR
ON
INE
SO
DIU
MC
YT
OM
EL
OR
AL
YE
S
TH
YR
OID
AR
MO
UR
TH
YR
OID
OR
AL
YE
S
TH
YR
OID
TH
YR
OID
OR
AL
YE
S
Q5
BT
OP
ICA
L A
NT
IBA
CT
ER
IALS
CA
DE
XO
ME
R I
OD
INE
IOD
OS
OR
BT
OP
ICA
LN
O
CH
LOR
HE
XID
INE
GLU
CO
NA
TE
BE
TA
SE
PT
TO
PIC
AL
NO
CLI
OQ
UIN
OL-
HY
DR
OC
OR
TIS
ON
EC
LIO
QU
INO
L-H
YD
RO
CO
RT
ISO
NE
TO
PIC
AL
NO
HE
XA
CH
LOR
OP
HE
NE
P
HIS
OH
EX
TO
PIC
AL
NO
HY
DR
OC
OR
TIS
ON
E-I
OD
OQ
UIN
OL
HY
DR
OC
OR
TIS
ON
E-I
OD
OQ
UIN
OL
TO
PIC
AL
NO
IOD
OQ
UIN
OL-
HY
DR
OC
OR
TIS
ON
E-A
LOE
PO
LYS
AC
CH
AR
IDE
ALC
OR
TIN
AT
OP
ICA
LN
O
PO
VID
ON
E-I
OD
INE
BE
TA
DIN
ET
OP
ICA
LN
O
ZE
PH
IRA
N C
HLO
RID
EZ
EP
HIR
AN
CH
LOR
IDE
TO
PIC
AL
NO
Q5
WT
OP
ICA
L A
NT
IBIO
TIC
S
BA
CIT
RA
CIN
ZIN
CB
AC
ITR
AC
IN
TO
PIC
AL
NO
BA
CIT
RA
CIN
-PO
LYM
YX
IN B
PO
LYS
PO
RIN
TO
PIC
AL
NO
CLI
ND
AM
YC
IN P
HO
SP
HA
TE
CLE
OC
IN-T
TO
PIC
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
37
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
TO
PIC
AL
AN
TIB
IOT
ICS
(C
ON
T)
ER
YT
HR
OM
YC
IN
ER
YT
OP
ICA
LN
O
ER
YT
HR
OM
YC
IN-B
EN
ZO
YL
PE
RO
XID
EE
RY
TH
RO
MY
CIN
-BE
NZ
OY
L P
ER
OX
IDE
TO
PIC
AL
NO
GE
NT
AM
ICIN
SU
LFA
TE
GE
NT
AM
ICIN
SU
LFA
TE
TO
PIC
AL
NO
MU
PIR
OC
IN C
ALC
IUM
BA
CT
RO
BA
NT
OP
ICA
LN
ON
EO
MY
CIN
-BA
CIT
RA
CIN
-PO
LYM
YX
IN W
/
LID
OC
AIN
EN
EO
SP
OR
IN P
LUS
TO
PIC
AL
NO
NE
OM
YC
IN-P
OLY
MY
XIN
B-G
RA
MIC
IDIN
N
EO
SP
OR
INT
OP
ICA
LN
O
Q5
XT
OP
ICA
L A
NT
IBIO
TIC
S S
TE
RO
ID
NE
OM
YC
IN-P
OLY
MY
XIN
-HC
C
OR
TIS
PO
RIN
TO
PIC
AL
NO
Q5
FT
OP
ICA
L A
NT
IFU
NG
ALS
BU
TE
NA
FIN
E H
CL
ME
NT
AX
TO
PIC
AL
NO
CIC
LOP
IRO
X
LOP
RO
XT
OP
ICA
LN
O
CLO
TR
IMA
ZO
LELO
TR
IMIN
AF
TO
PIC
AL
NO
CLO
TR
IMA
ZO
LE W
/ B
ET
AM
ET
HA
SO
NE
LOT
RIS
ON
ET
OP
ICA
LN
O
EC
ON
AZ
OLE
NIT
RA
TE
EC
ON
AZ
OLE
NIT
RA
TE
TO
PIC
AL
NO
GE
NT
IAN
VIO
LET
GE
NT
IAN
VIO
LET
TO
PIC
AL
NO
KE
TO
CO
NA
ZO
LE
EX
TIN
AT
OP
ICA
LN
O
MIC
ON
AZ
OLE
NIT
RA
TE
MIC
AT
INT
OP
ICA
LN
O
MIC
ON
AZ
OLE
NIT
RA
TE
ZE
AS
OR
B-A
FT
OP
ICA
LN
OM
ICO
NA
ZO
LE-Z
INC
OX
IDE
-WH
ITE
PE
TR
OLA
TU
M
VU
SIO
NT
OP
ICA
LN
O
NA
FT
IFIN
E H
CL
NA
FT
INT
OP
ICA
LN
O
NY
ST
AT
INM
YC
OS
TA
TIN
TO
PIC
AL
NO
NY
ST
AT
IN-T
RIA
MC
INO
LON
EM
YC
OLO
G_
IIT
OP
ICA
LN
O
OX
ICO
NA
ZO
LE N
ITR
AT
EO
XIS
TA
TT
OP
ICA
LN
O
SA
LIC
YLI
C A
CID
& B
EN
ZO
IC A
CID
BE
NS
AL
HP
TO
PIC
AL
NO
SE
RT
AC
ON
AZ
OLE
NIT
RA
TE
ER
TA
CZ
OT
OP
ICA
LN
O
SU
LCO
NA
ZO
LE N
ITR
AT
E
EX
ELD
ER
MT
OP
ICA
LN
O
TE
RB
INA
FIN
E H
CL
LAM
ISIL
AT
TO
PIC
AL
NO
TO
LNA
FT
AT
E
TIN
AC
TIN
TO
PIC
AL
NO
Q5
ET
OP
ICA
L A
NT
I-IN
FLA
MM
AT
OR
Y
DIC
LOF
EN
AC
SO
DIU
M
VO
LTA
RE
NT
OP
ICA
LN
O
Q5
NT
OP
ICA
L A
NT
INE
OP
LAS
TIC
S
DIC
LOF
EN
AC
SO
DIU
M (
AC
TIN
IC K
ER
AT
OS
ES
)S
OLA
RA
ZE
TO
PIC
AL
YE
S
FLU
OR
OU
RA
CIL
CA
RA
CT
OP
ICA
LY
ES
Q5
PT
OP
ICA
L A
NT
INF
LAM
MA
TO
RY
PR
EP
ALC
LOM
ET
AS
ON
E D
IPR
OP
ION
AT
EA
CLO
VA
TE
TO
PIC
AL
NO
AM
CIN
ON
IDE
A
MC
INO
NID
ET
OP
ICA
LN
O
BE
TA
ME
TH
AS
ON
E D
IPR
OP
ION
AT
ED
IPR
OLE
NE
TO
PIC
AL
NO
BE
TA
ME
TH
AS
ON
E V
ALE
RA
TE
LU
XIQ
TO
PIC
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
38
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
TO
PIC
AL
AN
TIN
FLA
MM
AT
OR
Y P
RE
P (
CO
NT
)C
LOB
ET
AS
OL
PR
OP
ION
AT
EO
LUX
TO
PIC
AL
NO
CLO
BE
TA
SO
L P
RO
PIO
NA
TE
C
LOB
EX
TO
PIC
AL
NO
CLO
CO
RT
OLO
NE
PIV
ALA
TE
C
LOD
ER
MT
OP
ICA
LN
O
DE
SO
NID
EV
ER
DE
SO
TO
PIC
AL
NO
DE
SO
XIM
ET
AS
ON
ET
OP
ICO
RT
TO
PIC
AL
NO
DIF
LOR
AS
ON
E D
IAC
ET
AT
ED
IFLO
RA
SO
NE
DIA
CE
TA
TE
TO
PIC
AL
NO
DIF
LOR
AS
ON
E D
IAC
ET
AT
E
AP
EX
ICO
N E
TO
PIC
AL
NO
FLU
OC
INO
LON
E A
CE
TO
NID
E
DE
RM
A-S
MO
OT
HE
-FS
TO
PIC
AL
NO
FLU
OC
INO
NID
EV
AN
OS
TO
PIC
AL
NO
FLU
RA
ND
RE
NO
LID
E
CO
RD
RA
NT
OP
ICA
LN
O
FLU
TIC
AS
ON
E P
RO
PIO
NA
TE
CU
TIV
AT
ET
OP
ICA
LN
O
HA
LCIN
ON
IDE
HA
LOG
TO
PIC
AL
NO
HA
LOB
ET
AS
OL
PR
OP
ION
AT
E
ULT
RA
VA
TE
TO
PIC
AL
NO
HY
DR
OC
OR
TIS
ON
EC
OR
TIZ
ON
E 1
0T
OP
ICA
LN
O
HY
DR
OC
OR
TIS
ON
E A
CE
TA
TE
HY
DR
OC
OR
TIS
ON
ET
OP
ICA
LN
O
HY
DR
OC
OR
TIS
ON
E B
UT
YR
AT
EC
OR
TA
IDT
OP
ICA
LN
OH
YD
RO
CO
RT
ISO
NE
BU
TY
RA
TE
HY
DR
OP
HIL
IC
LIP
O B
AS
ELO
CO
ID L
IPO
CR
EA
MT
OP
ICA
LN
O
HY
DR
OC
OR
TIS
ON
E P
RO
BU
TA
TE
P
AN
DE
LT
OP
ICA
LN
O
HY
DR
OC
OR
TIS
ON
E V
ALE
RA
TE
VA
LIS
ON
ET
OP
ICA
LN
O
HY
DR
OC
OR
TIS
ON
E-A
LOE
VE
RA
H
YD
RO
CO
RT
ISO
NE
-ALO
E V
ER
A C
RE
AM
T
OP
ICA
LN
O
MO
ME
TA
SO
NE
FU
RO
AT
EE
LOC
ON
TO
PIC
AL
NO
PR
ED
NIC
AR
BA
TE
DE
RM
AT
OP
TO
PIC
AL
NO
TR
IAM
CIN
OLO
NE
AC
ET
ON
IDE
KE
NA
LOG
TO
PIC
AL
NO
Q5
RT
OP
ICA
L A
NT
IPA
RA
SIT
ICS
W4
MT
OP
ICA
L A
NT
IPA
RA
SIT
ICS
CR
OT
AM
ITO
N
EU
RA
XT
OP
ICA
LN
O
LIN
DA
NE
LIN
DA
NE
TO
PIC
AL
NO
MA
LAT
HIO
NO
VID
ET
OP
ICA
LN
O
NIT
AZ
OX
AN
IDE
ALI
NIA
OR
AL
NO
PE
RM
ET
HR
IN
AC
TIC
INT
OP
ICA
LN
O
PY
RE
TH
RIN
S-P
IPE
RO
NY
L B
UT
OX
IDE
R
IDT
OP
ICA
LN
O
W8
NT
OP
ICA
L A
NT
ISE
PT
DR
YIN
G A
GE
NT
S
FO
RM
ALD
EH
YD
EF
OR
MA
LAZ
TO
PIC
AL
NO
Q5
VT
OP
ICA
L A
NT
IVIR
ALS
AC
YC
LOV
IRZ
OV
IRA
XT
OP
ICA
LN
O
PE
NC
ICLO
VIR
D
EN
AV
IRT
OP
ICA
LN
O
L9D
TO
PIC
AL
HY
PE
RP
IGM
EN
TA
TIO
N A
G
ME
TH
OX
SA
LEN
OX
SO
RA
LEN
TO
PIC
AL
YE
S
T0
DT
OP
ICA
L H
YP
ER
TR
ICH
OT
C-E
YE
LAS
H
BIM
AT
OP
RO
ST
LAT
ISS
ET
OP
ICA
LN
O
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
39
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
Q5
KT
OP
ICA
L IM
MU
NO
SU
PP
RE
SS
IVE
AG
T
PIM
EC
RO
LIM
US
E
LID
EL
TO
PIC
AL
YE
S
TA
CR
OLI
MU
SP
RO
TO
PIC
TO
PIC
AL
YE
S
Q5
HT
OP
ICA
L LO
CA
L A
NE
ST
HE
TIC
S
BE
NZ
OC
AIN
E
BE
NZ
OC
AIN
E A
ER
OS
OL
10
%
TO
PIC
AL
NO
BU
TA
MB
EN
-TE
TR
AC
AIN
E-B
EN
ZO
CA
INE
C
ET
AC
AIN
ET
OP
ICA
LN
O
DIB
UC
AIN
ED
IBU
CA
INE
TO
PIC
AL
NO
ET
HY
L C
HLO
RID
EE
TH
YL
CH
LOR
IDE
TO
PIC
AL
NO
HY
DR
OC
OR
TIS
ON
E A
CE
-PR
AM
OX
INE
-ALO
E
PO
LYS
AC
CH
NO
VA
CO
RT
TO
PIC
AL
NO
LID
OC
AIN
E
AN
EC
RE
AM
TO
PIC
AL
NO
LID
OC
AIN
E H
CL
RE
GE
NE
CA
RE
HA
TO
PIC
AL
NO
LID
OC
AIN
E P
AT
CH
LI
DO
DE
RM
TO
PIC
AL
NO
Cla
im m
ust
be
all
ow
ed
fo
r p
ost
he
rpe
tic
ne
ura
lgia
LID
OC
AIN
E-H
YD
RO
CO
RT
ISO
NE
AC
ET
AT
E
LID
AM
AN
TLE
HC
TO
PIC
AL
NO
LID
OC
AIN
E-P
RIL
OC
AIN
EE
MLA
TO
PIC
AL
NO
LID
OC
AIN
E-T
ET
RA
CA
INE
PA
TC
HS
YN
ER
AT
OP
ICA
LN
OP
EN
TA
FLU
OR
OP
RO
PA
NE
-
TE
TR
AF
LUO
RO
ET
HA
NE
AE
RO
PE
NT
AF
LUO
RO
PR
OP
AN
E-
TE
TR
AF
LUO
RO
ET
HA
NE
AE
RO
T
OP
ICA
LN
O
PR
AM
OX
INE
HC
LS
AR
NA
SE
NS
ITIV
ET
OP
ICA
LN
O
PR
AM
OX
INE
HC
L-H
YD
RO
CO
RT
ISO
NE
PR
AM
OS
ON
ET
OP
ICA
LN
O
T0
BT
OP
ICA
L P
LEU
RO
MU
TIL
IN D
ER
IV.
CA
LCIP
OT
RIE
NE
-BE
TA
ME
TH
AS
ON
E
DIP
RO
PIO
NA
TE
A
LTA
BA
XT
OP
ICA
LY
ES
Q5
AT
OP
ICA
L P
RE
PA
RA
TIO
NS
, M
ISC
EM
OLL
IEN
TC
ET
AP
HIL
TO
PIC
AL
NO
SO
DIU
M C
HLO
RID
E
S
OD
IUM
CH
LO
RID
E E
XT
ER
NA
L S
OLN
TO
PIC
AL
NO
Q5
ST
OP
ICA
L S
ULF
ON
AM
IDE
S
MA
FE
NID
E A
CE
TA
TE
S
ULF
AM
YLO
NT
OP
ICA
LN
O
SIL
VE
R S
ULF
AD
IAZ
INE
S
ILV
AD
EN
ET
OP
ICA
LN
O
SU
LFA
CE
TA
MID
E S
OD
IUM
W/
SU
LFU
RR
OS
AD
ER
MT
OP
ICA
LN
O
SU
LFA
CE
TA
MID
E S
OD
IUM
-SU
LFU
RR
OS
ULA
TO
PIC
AL
NO
T0
AT
OP
ICA
L V
IT D
AN
ALO
G/S
TE
RO
ID
CA
LCIP
OT
RIE
NE
-BE
TA
ME
TH
AS
ON
E
DIP
RO
PIO
NA
TE
TA
CLO
NE
XT
OP
ICA
LY
ES
L0B
TO
PIC
AL/
MU
CO
US
ME
MB
RA
NC
E/S
UB
CO
LLA
GE
NA
SE
SA
NT
YL
TO
PIC
AL
NO
PA
PA
IN-U
RE
A
ALL
AN
EN
ZY
ME
TO
PIC
AL
NO
PA
PA
IN-U
RE
A
KO
VIA
OIN
TM
EN
TT
OP
ICA
LN
O
PA
PA
IN-U
RE
A-C
HLO
RO
PH
YLL
INA
LLA
NF
ILLE
NZ
YM
ET
OP
ICA
LN
O
TR
YP
SIN
TR
YP
SIN
TO
PIC
AL
NO
TR
YP
SIN
W/
CA
ST
OR
OIL
& P
ER
UV
IAN
BA
LSA
MG
RA
NU
LEX
TO
PIC
AL
NO
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
40
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
W4
ET
RIC
HO
MO
NA
CID
ES
ME
TR
ON
IDA
ZO
LE
FLA
GY
L E
RO
RA
LN
O
H2
UT
RIC
YC
LIC
AN
TID
EP
RE
SS
RE
LAT
ED
AM
ITR
IPT
YLI
NE
HC
LE
LAV
ILO
RA
LN
O
AM
OX
AP
INE
A
SC
EN
DIN
OR
AL
NO
CLO
MIP
RA
MIN
E H
CL
CLO
MID
OR
AL
NO
DE
SIP
RA
MIN
E H
CL
NO
RP
RA
MIN
EO
RA
LN
O
DO
XE
PIN
HC
LS
INE
QU
AN
OR
AL
NO
IMIP
RA
MIN
E H
CL
TO
FR
AN
IL
OR
AL
NO
IMIP
RA
MIN
E P
AM
OA
TE
TO
FR
AN
IL-P
MO
RA
LN
O
MA
PR
OT
ILIN
E H
CL
LUD
IOM
ILO
RA
LN
O
NO
RT
RIP
TY
LIN
E H
CL
PA
ME
LOR
OR
AL
NO
PR
OT
RIP
TY
LIN
E H
CL
VIV
AC
TIL
OR
AL
NO
TR
IMIP
RA
MIN
E M
ALE
AT
E
SU
RM
ON
TIL
OR
AL
NO
S2
JT
UM
OR
NE
CR
OS
IS F
AC
TO
R I
NH
IBIT
AD
ALI
MU
MA
BH
UM
IRA
SU
B-Q
YE
S
ET
AN
ER
CE
PT
EN
BR
EL
SU
B-Q
YE
S
H7
YT
X F
OR
AT
TN
DE
F-A
DH
D,
NR
I-T
YP
E
AT
OM
OX
ET
INE
HC
L S
TR
AT
TE
RA
OR
AL
YE
S
R1
AU
NIA
RY
TR
AC
T A
NT
ISP
AS
MO
DIC
FE
SO
TE
RO
DIN
E F
UM
AR
AT
ET
OV
IAZ
OR
AL
YE
S
FLA
VO
XA
TE
HC
LF
LAV
OX
AT
E H
CL
OR
AL
YE
S
OX
YB
UT
YN
IN C
HLO
RID
ED
ITR
OP
AN
XL
OR
AL
YE
S
OX
YB
UT
YN
IN C
HLO
RID
EO
XY
BU
TY
NIN
CH
LOR
IDE
OR
AL
YE
S
OX
YB
UT
YN
IN C
HLO
RID
E T
DG
ELN
IQU
ET
RA
NS
DE
RM
YE
S
OX
YB
UT
YN
IN T
D P
AT
CH
O
XY
TR
OL
TR
AN
SD
ER
MY
ES
TO
LTE
RO
DIN
E T
AR
TR
AT
E
DE
TR
OL
OR
AL
YE
S
TR
OS
PIU
M C
HLO
RID
E
SA
NC
TU
RA
OR
AL
YE
S
R5
BU
RIN
AR
Y A
NE
LGE
SIC
AG
EN
TS
PE
NT
OS
AN
PO
LYS
ULF
AT
E S
OD
IUM
ELM
IRO
NO
RA
LY
ES
R5
AU
RIN
AR
Y A
NE
ST
HE
TIC
S
PH
EN
AZ
OP
YR
IDIN
E H
CL
PH
EN
AZ
OP
YR
IDIN
E H
CL
OR
AL
YE
S
R1
SU
RIN
AR
Y P
H M
OD
IFIE
RS
CIT
RIC
AC
ID &
D-G
LUC
ON
IC A
CID
R
EN
AC
IDIN
IRR
IGA
TIO
NY
ES
Ina
ctiv
eU
RO
QID
-AC
ID N
O.2
OR
AL
YE
SP
OT
PH
OS
MO
NO
BA
SIC
W/S
OD
PH
OS
DI
&
MO
NO
BA
SK
-PH
OS
NE
UT
RA
LO
RA
LY
ES
PO
TA
SS
IUM
& S
OD
IUM
AC
ID P
HO
SP
HA
TE
S
K-P
HO
S M
.F.
OR
AL
YE
S
PO
TA
SS
IUM
CIT
RA
TE
UR
OC
IT-K
OR
AL
YE
S
PO
TA
SS
IUM
CIT
RA
TE
& C
ITR
IC A
CID
CY
TR
A-K
OR
AL
YE
S
SO
DIU
M C
ITR
AT
E &
CIT
RIC
AC
IDC
YT
RA
-2O
RA
LY
ES
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
41
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
R1
IU
RIN
AR
YT
RA
CT
AN
TIS
PA
S-M
(3)S
EL
DA
RIF
EN
AC
IN H
YD
RO
BR
OM
IDE
EN
AB
LEX
OR
AL
YE
S
SO
LIF
EN
AC
IN S
UC
CIN
AT
EV
ES
ICA
RE
OR
AL
YE
S
Q4
WV
AG
INA
L A
NT
IBIO
TIC
S
ME
TR
ON
IDA
ZO
LE
VA
ND
AZ
OLE
VA
GIN
AL
YE
S
Q4
FV
AG
INA
L A
NT
IFU
NG
ALS
MIC
ON
AZ
OLE
NIT
RA
TE
MO
NIS
TA
T 3
VA
GIN
AL
YE
S
TE
RC
ON
AZ
OLE
T
ER
ZO
LV
AG
INA
LY
ES
Q4
BV
AG
INA
L A
NT
ISE
PT
ICS
OX
YQ
UIN
OLO
NE
SU
LFA
TE
-PH
4T
RIM
O-S
AN
VA
GIN
AL
NO
Q4
KV
AG
INA
L E
ST
RO
GE
N P
RE
PA
RA
TIO
N
ES
TR
AD
IOL
ES
TR
AD
IOL
VA
GIN
AL
VA
GIN
AL
NO
Q4
SV
AG
INA
L S
ULF
ON
AM
IDE
S
SU
LFA
NIL
AM
IDE
A
VC
VA
GIN
AL
YE
S
W1
JV
AN
CO
MY
CIN
AN
D D
ER
IVA
TIV
ES
VA
NC
OC
IN H
CL
VA
NC
OC
IN H
CL
OR
AL
NO
VA
NC
OM
YC
IN H
CL
VA
NC
OM
YC
IN H
CL
INT
RA
VE
NN
O
A7
JV
AS
OD
ILA
TO
RS
, C
OM
BIN
AT
ION
ISO
SO
RB
IDE
DIN
ITR
AT
E-H
YD
RA
LAZ
INE
HC
LB
IDIL
OR
AL
YE
S
U6
NV
EH
ICLE
S
U6
PV
EH
ICLE
S
CO
CO
A B
UT
TE
RC
OC
OA
BU
TT
ER
TO
PIC
AL
NO
SO
RB
ITO
LS
OR
BIT
OL
MIS
CE
LLN
O
C6
AV
ITA
MIN
A P
RE
PA
RA
TIO
NS
VIT
AM
IN A
VIT
AM
IN A
OR
AL
YE
S
C6
BV
ITA
MIN
B P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
B-C
OM
PLE
X W
/ C
& F
OLI
C A
CID
N
EP
HR
OC
AP
SO
RA
LY
ES
B-C
OM
PLE
X W
/ C
-BIO
TIN
-MIN
ER
ALS
& F
OLI
C
AC
IDD
IAT
X Z
NO
RA
LY
ES
FO
LIC
AC
ID-P
YR
IDO
XIN
E-C
YA
NO
CO
BA
LAM
IN
FO
LBIC
OR
AL
YE
S
FO
LIC
AC
ID-P
YR
IDO
XIN
E-C
YA
NO
CO
BA
LAM
IN
FO
LTX
OR
AL
YE
S
FO
LIC
AC
ID-V
ITA
MIN
B6
-VIT
AM
IN B
12
F
OLG
AR
D R
XO
RA
LY
ES
L-M
ET
HY
LFO
LAT
E W
/ V
IT B
12
-VIT
B6
-VIT
B2
C
ER
EF
OLI
NO
RA
LY
ES
L-M
ET
HY
LFO
LAT
E W
/ V
IT B
6-V
IT B
12
M
ET
AN
XO
RA
LY
ES
L-M
ET
HY
LFO
LAT
E-M
ET
HY
LCO
BA
LAM
IN-
AC
ET
YLC
YS
TC
ER
EF
OLI
N N
AC
OR
AL
YE
S
L-M
ET
HY
LFO
LAT
E-M
ET
HY
LCO
BA
LAM
IN-
AC
ET
YLC
YS
T
L-M
ET
HY
LFO
LAT
E-M
ET
HY
LCO
BA
LAM
IN-
AC
ET
YLC
YS
TO
RA
LY
ES
PO
TA
SS
IUM
AM
INO
BE
NZ
OA
TE
AM
INO
BE
NZ
OA
TE
PO
TA
SS
IUM
OR
AL
YE
S
AP
PE
ND
IX A
BW
C O
UT
PA
TIE
NT
M
ED
ICA
TIO
N F
OR
MU
LAR
Y
Pa
ge
42
of
42
Th
era
pe
uti
c C
lass
Co
de
Th
era
pe
uti
c C
lass
Co
de
De
scri
pti
on
2G
en
eri
c N
am
e
Re
pre
sen
tati
ve
bra
nd
na
me
(If
on
e i
s in
use
), N
OT
E:
Bra
nd
na
me
pro
du
cts
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h O
AC
41
23
-6-2
1D
osa
ge
Fo
rm
Re
qu
ire
s P
rio
r
Au
tho
riza
tio
n o
r
Re
late
d C
on
dit
ion
Ap
pro
ve
d i
n C
laim
Co
ve
rag
e r
est
rict
ion
s o
r li
mit
ati
on
s fo
r sp
eci
fic
dru
gs
or
do
sag
e f
orm
s a
re l
iste
d
wit
h t
he
re
spe
ctiv
e d
rug
s b
elo
w.
Un
less
oth
erw
ise
re
stri
cte
d,
all
do
sag
e f
orm
s
an
d s
tre
ng
ths
of
a l
iste
d d
rug
are
eli
gib
le f
or
reim
bu
rse
me
nt
in a
cco
rda
nce
wit
h
OA
C 4
12
3-6
-21
.
VIT
AM
IN B
PR
EP
AR
AT
ION
S (
CO
NT
)P
OT
AS
SIU
M A
MIN
OB
EN
ZO
AT
EP
OT
AB
AO
RA
LY
ES
VIT
AM
INS
W/
LIP
OT
RO
PIC
S
BA
LAN
CE
D B
-10
0O
RA
LY
ES
C6
TV
ITA
MIN
B1
PR
EP
AR
AT
ION
S
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
TH
IAM
INE
HC
L B
-1O
RA
LY
ES
C6
LV
ITA
MIN
B1
2 P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
CY
AN
OC
OB
ALA
MIN
V
ITA
MIN
B-1
2O
RA
LY
ES
C6
RV
ITA
MIN
B2
PR
EP
AR
AT
ION
S
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
RIB
OF
LAV
IN
VIT
AM
IN B
-2O
RA
LY
ES
C6
QV
ITA
MIN
B6
PR
EP
AR
AT
ION
S
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
PY
RID
OX
INE
V
ITA
MIN
B-6
OR
AL
YE
S
C6
CV
ITA
MIN
C P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
AS
CO
RB
IC A
CID
VIT
AM
IN C
OR
AL
YE
S
C6
DV
ITA
MIN
D P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
ER
GO
CA
LCIF
ER
OL
CA
LCIF
ER
OL
OR
AL
YE
S
C6
EV
ITA
MIN
E P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
B-C
OM
PLE
X W
/ C
& E
+ Z
N
Z-G
EN
OR
AL
YE
S
VIT
AM
IN E
V
ITA
MIN
EO
RA
LY
ES
C6
KV
ITA
MIN
K P
RE
PA
RA
TIO
NS
All
co
mb
ina
tio
ns
an
d s
tre
ng
ths
of
ora
l d
osa
ge
fo
rms
are
co
ve
red
fo
r a
llo
we
d
con
dit
ion
s
PH
YT
ON
AD
ION
E
ME
PH
YT
ON
OR
AL
YE
S
A1
BX
AN
TH
INE
S
AM
INO
PH
YLL
INE
AM
INO
PH
YLL
INE
Ora
lN
O
TH
EO
PH
YLL
INE
TH
EO
PH
YLL
INE
Ora
lN
O
TH
EO
PH
YLL
INE
ELI
XIR
ELI
XO
PH
YLL
INO
ral
NO
C3
CZ
INC
RE
PLA
CE
ME
NT
All
zin
c sa
lts
an
d o
ral
do
sag
e f
orm
s a
re c
ov
ere
d f
or
all
ow
ed
co
nd
itio
ns
ZIN
C S
ULF
AT
EO
RA
ZIN
CO
RA
LY
ES